<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="review-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Front Pediatr</journal-id><journal-id journal-id-type="iso-abbrev">Front Pediatr</journal-id><journal-id journal-id-type="pmc-domain-id">2282</journal-id><journal-id journal-id-type="pmc-domain">frontpediatrics</journal-id><journal-id journal-id-type="publisher-id">Front. Pediatr.</journal-id><journal-title-group><journal-title>Frontiers in Pediatrics</journal-title></journal-title-group><issn pub-type="epub">2296-2360</issn><publisher><publisher-name>Frontiers Media SA</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC10991792</article-id><article-id pub-id-type="pmcid-ver">PMC10991792.1</article-id><article-id pub-id-type="pmcaid">10991792</article-id><article-id pub-id-type="pmcaiid">10991792</article-id><article-id pub-id-type="pmid">38577634</article-id><article-id pub-id-type="doi">10.3389/fped.2024.1357970</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Pediatrics</subject><subj-group><subject>Mini Review</subject></subj-group></subj-group></article-categories><title-group><article-title>Sex differences in neonatal outcomes following prenatal opioid exposure</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Madurai</surname><given-names initials="NK">Nethra K.</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="cor1" ref-type="corresp">*</xref><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://loop.frontiersin.org/people/1976702/overview"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/><role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/><role content-type="https://credit.niso.org/contributor-roles/methodology/"/><role content-type="https://credit.niso.org/contributor-roles/investigation/"/><role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/><role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Jantzie</surname><given-names initials="LL">Lauren L.</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref><xref rid="aff3" ref-type="aff">
<sup>3</sup>
</xref><xref rid="aff4" ref-type="aff">
<sup>4</sup>
</xref><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://loop.frontiersin.org/people/247147/overview"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/><role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/><role content-type="https://credit.niso.org/contributor-roles/methodology/"/><role content-type="https://credit.niso.org/contributor-roles/investigation/"/><role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/><role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Yen</surname><given-names initials="E">Elizabeth</given-names></name><xref rid="aff5" ref-type="aff">
<sup>5</sup>
</xref><xref rid="aff6" ref-type="aff">
<sup>6</sup>
</xref><xref rid="aff7" ref-type="aff">
<sup>7</sup>
</xref><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://loop.frontiersin.org/people/1116914/overview"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/><role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/><role content-type="https://credit.niso.org/contributor-roles/supervision/"/><role content-type="https://credit.niso.org/contributor-roles/project-administration/"/><role content-type="https://credit.niso.org/contributor-roles/methodology/"/><role content-type="https://credit.niso.org/contributor-roles/investigation/"/><role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/><role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/><role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/></contrib></contrib-group><aff id="aff1"><label><sup>1</sup></label><institution>Division of Neonatal-Perinatal Medicine, Department of Pediatrics, Johns Hopkins University School of Medicine</institution>, <addr-line>Baltimore, MD</addr-line>, <country>United States</country></aff><aff id="aff2"><label><sup>2</sup></label><institution>Department of Neurodevelopmental Medicine, Phelps Center for Cerebral Palsy and Neurodevelopmental Medicine, Kennedy Krieger Institute</institution>, <addr-line>Baltimore, MD</addr-line>, <country>United States</country></aff><aff id="aff3"><label><sup>3</sup></label><institution>Department of Neurology, Johns Hopkins University School of Medicine</institution>, <addr-line>Baltimore, MD</addr-line>, <country>United States</country></aff><aff id="aff4"><label><sup>4</sup></label><institution>Division of Pediatric Neurosurgery, Department of Neurosurgery, Johns Hopkins University School of Medicine</institution>, <addr-line>Baltimore, MD</addr-line>, <country>United States</country></aff><aff id="aff5"><label><sup>5</sup></label><institution>Mother Infant Research Institute (MIRI), Tufts Medical Center</institution>, <addr-line>Boston, MA</addr-line>, <country>United States</country></aff><aff id="aff6"><label><sup>6</sup></label><institution>Division of Newborn Medicine, Tufts Medicine Pediatrics-Boston Children's</institution>, <addr-line>Boston, MA</addr-line>, <country>United States</country></aff><aff id="aff7"><label><sup>7</sup></label><institution>Department of Pediatrics, Tufts University School of Medicine</institution>, <addr-line>Boston, MA</addr-line>, <country>United States</country></aff><author-notes><fn fn-type="edited-by"><p><bold>Edited by:</bold> Brady Atwood, Indiana University Bloomington, United States</p></fn><fn fn-type="edited-by"><p><bold>Reviewed by:</bold> Sraboni Chaudhury, University of Michigan, United States</p></fn><corresp id="cor1"><label>*</label><bold>Correspondence:</bold> Nethra K. Madurai <email>nethra@jhmi.edu</email></corresp></author-notes><pub-date pub-type="epub"><day>21</day><month>3</month><year>2024</year></pub-date><pub-date pub-type="collection"><year>2024</year></pub-date><volume>12</volume><issue-id pub-id-type="pmc-issue-id">454091</issue-id><elocation-id>1357970</elocation-id><history><date date-type="received"><day>19</day><month>12</month><year>2023</year></date><date date-type="accepted"><day>04</day><month>3</month><year>2024</year></date></history><pub-history><event event-type="pmc-release"><date><day>21</day><month>03</month><year>2024</year></date></event><event event-type="pmc-live"><date><day>04</day><month>04</month><year>2024</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-11-11 16:25:31.333"><day>11</day><month>11</month><year>2024</year></date></event></pub-history><permissions><copyright-statement>&#169; 2024 Madurai, Jantzie and Yen.</copyright-statement><copyright-year>2024</copyright-year><copyright-holder>Madurai, Jantzie and Yen</copyright-holder><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open-access article distributed under the terms of the <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License (CC BY)</ext-link>. The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="fped-12-1357970.pdf"/><abstract><p>The impact of the opioid epidemic on pregnant people and children is a growing public health crisis. Understanding how opioids affect the developing brain during pregnancy and postnatally remains a critical area of investigation. Biological sex plays a crucial role in all physiologic processes, with the potential for a significant impact on neonatal outcomes, including those infants with opioid exposure. Here, we aim to explore current literature on the effect of sex on neonatal outcomes following prenatal opioid exposure. Sex differences in adults with opioid use disorder have been well studied, including increased mortality among males and higher rates of psychiatric comorbidities and likelihood of relapse in females. However, such differences are not yet well understood in neonates. Emerging clinical data suggest sex-specific effects in infants with prenatal opioid exposure on the expression of genes related to feeding regulation and reward signaling pathways. Increased susceptibility to white matter injury has also been noted in female infants following prenatal opioid exposure. Understanding the impact of sex as a biological variable on neonatal outcomes following prenatal opioid exposure is paramount to improving the health and well-being of infants, children, and adults impacted by the opioid epidemic.</p></abstract><kwd-group><kwd>prenatal opioid exposure</kwd><kwd>neonatal opioid withdrawal syndrome</kwd><kwd>opioid use disorder</kwd><kwd>sex differences</kwd><kwd>newborn</kwd><kwd>development</kwd><kwd>pregnancy</kwd></kwd-group><funding-group><award-group><funding-source id="cn001">National Institutes of Health/National Institute of Drug Abuse</funding-source><award-id award-type="contract" rid="cn001">1U18DA052402</award-id></award-group><award-group><funding-source id="cn002">National Institutes of Health R01</funding-source><award-id award-type="contract" rid="cn002">R01HL139492</award-id></award-group><award-group><funding-source id="cn004">Johns Hopkins Children&#8217;s Innovation fund to LJ, the Institutional Training Grant for Clinician Scientists in Pediatric Critical Cardiopulmonary Disease</funding-source><award-id award-type="contract" rid="cn004">T32HL125239</award-id></award-group><award-group><funding-source id="cn005">NIH K12 Building Interdisciplinary Research Career in Women&#8217;s Health (BIRCWH)</funding-source><award-id award-type="contract" rid="cn005">NIH/NIDA K23, DA056847</award-id></award-group><award-group><funding-source id="cn003">Blaustein Pain Research Fund</funding-source></award-group></funding-group><funding-group><funding-statement>The author(s) declare financial support was received for the research, authorship, and/or publication of this article.</funding-statement><funding-statement>The authors are grateful for the generous funding provided by the National Institutes of Health/National Institute of Drug Abuse 1U18DA052402 to LJ, the National Institutes of Health R01 to LJ (R01HL139492), the Blaustein Pain Research Fund to LJ, the Johns Hopkins Children&#8217;s Innovation fund to LJ, the Institutional Training Grant for Clinician Scientists in Pediatric Critical Cardiopulmonary Disease (T32HL125239) to NM, Tufts Medicine Career Development Award to EY, the Charles H. Hood Foundation Grant to EY, the NIH K12 Building Interdisciplinary Research Career in Women&#8217;s Health (BIRCWH) Grant to EY, and the NIH/NIDA K23 to EY (DA056847).</funding-statement></funding-group><counts><fig-count count="1"/><table-count count="1"/><equation-count count="0"/><ref-count count="90"/><page-count count="0"/><word-count count="0"/></counts><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>section-at-acceptance</meta-name><meta-value>Neonatology</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro" id="s1"><label>1</label><title>Introduction</title><p>Rates of opioid use disorder (OUD) among pregnant individuals and persons of childbearing age continue to rise (<xref rid="B1" ref-type="bibr">1</xref>), accompanied by a significant increase in neonatal abstinence syndrome (NAS), also known as neonatal opioid withdrawal syndrome (NOWS) (<xref rid="B2" ref-type="bibr">2</xref>&#8211;<xref rid="B7" ref-type="bibr">7</xref>). The diagnosis of NAS has risen more than five-fold from 2000 to 2016, highlighting the need for an improved understanding of risk factors associated with NAS to help inform prevention and tailor neonatal management (<xref rid="B4" ref-type="bibr">4</xref>, <xref rid="B8" ref-type="bibr">8</xref>). Current literature suggests certain factors during pregnancy that increase the risk of NAS, including opioid type, total opioid exposure, tobacco use, and selective serotonin receptor inhibitor (SSRI) use (<xref rid="B9" ref-type="bibr">9</xref>). However, other factors that influence the development of NAS and its complications remain poorly understood. There has been discrepant literature regarding the impact of sex in the development of NAS and its associated complications, with some studies showing increased vulnerability among male infants (<xref rid="B10" ref-type="bibr">10</xref>&#8211;<xref rid="B13" ref-type="bibr">13</xref>), while others are more equivocal (<xref rid="B14" ref-type="bibr">14</xref>, <xref rid="B15" ref-type="bibr">15</xref>).</p><p>Recognition of the fundamental role that sex plays in disease and health outcomes across the lifespan has grown over the previous decades (<xref rid="B16" ref-type="bibr">16</xref>). Sex-specific influences on the growth and development of a fetus during pregnancy start along the placental-fetal-brain axis, with salient differences noted from early in gestation (<xref rid="B16" ref-type="bibr">16</xref>&#8211;<xref rid="B19" ref-type="bibr">19</xref>) (<xref rid="F1" ref-type="fig">Figure&#160;1</xref>). Males reportedly have increased vulnerabilities in pregnancy outcomes and perinatal stressors, however, the biological mechanism underlying these differences and long-term outcomes is an active area of investigation (<xref rid="B19" ref-type="bibr">19</xref>&#8211;<xref rid="B26" ref-type="bibr">26</xref>). While opioids readily cross the placenta and blood-brain barrier in the developing fetus (<xref rid="B27" ref-type="bibr">27</xref>), it remains unclear how sex influences the impact of prenatal opioid exposure on infant and childhood outcomes. Here, we review preclinical and adult studies and summarize some of the proposed mechanisms for sex vulnerability in opioid-exposed neonates, including inflammation, different responses to stress, changes in the microbiome, and differences in cell death mechanisms (<xref rid="B28" ref-type="bibr">28</xref>&#8211;<xref rid="B37" ref-type="bibr">37</xref>) (<xref rid="T1" ref-type="table">Table 1</xref>).</p><fig position="float" id="F1" orientation="portrait"><label>Figure 1</label><caption><p>Mechanisms of sex-specific differences in outcomes following prenatal opioid exposure begins before birth and occurs due to complex interplay of many factors including, but not limited to: (1) sex-specific regulation of genetic and epigenetic changes influenced by maternal, placental and fetal factors (2) sex-specific influence on growth and neurodevelopment (3) sex-specific differences in immune and endocrine function. Figure created with <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://BioRender.com" ext-link-type="uri">BioRender.com</ext-link>.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="fped-12-1357970-g001.jpg"/></fig><table-wrap position="float" id="T1" orientation="portrait"><label>Table 1</label><caption><p>Summary of sex-specific alterations noted in endogenous and exogenous opioid functions.</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="left" span="1"/></colgroup><thead><tr><th valign="top" align="center" rowspan="1" colspan="1">Endogenous opioid effects</th><th valign="top" align="center" rowspan="1" colspan="1">Exogenous opioid effects</th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">
<list list-type="simple"><list-item><label>&#8226;</label><p>Neural cell specific functions:
<list list-type="simple"><list-item><label>&#9900;</label><p>Proper timing of neural cell maturation</p></list-item><list-item><label>&#9900;</label><p>Differential regulation of oligodendrocyte function and maturation based on sex</p></list-item></list></p></list-item></list></td><td valign="top" align="left" rowspan="1" colspan="1">
<list list-type="simple"><list-item><label>&#8226;</label><p>Sex-specific influence on opioid-receptor density, microglial function, synaptic pruning pathways, and dopamine reward pathways</p></list-item></list></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">
<list list-type="simple"><list-item><label>&#8226;</label><p>Sex-specific developmental program of neuroimmune system</p></list-item></list></td><td valign="top" align="left" rowspan="1" colspan="1">
<list list-type="simple"><list-item><label>&#8226;</label><p>Sex-specific variation in gut microbiota</p></list-item></list></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">
<list list-type="simple"><list-item><label>&#8226;</label><p>Influence of sex hormones on endogenous opioid signaling related to reproductive behaviors</p></list-item></list></td><td valign="top" align="left" rowspan="1" colspan="1">
<list list-type="simple"><list-item><label>&#8226;</label><p>Sex-specific hypothalamic-pituitary axis dysregulation</p></list-item></list></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">
<list list-type="simple"><list-item><label>&#8226;</label><p>Sex-specific differences in endogenous opioid peptides and receptors</p></list-item></list></td><td valign="top" align="left" rowspan="1" colspan="1">
<list list-type="simple"><list-item><label>&#8226;</label><p>Sex-specific effects on genetic and epigenetic changes in placenta and fetus</p></list-item></list></td></tr></tbody></table></table-wrap></sec><sec id="s2"><label>2</label><title>The influence of sex on opioid use and effects in offspring: preclinical and human data</title><sec id="s2a"><label>2.1</label><title>Sex differences in preclinical data</title><p>Preclinical studies of sex as a biological variable (SABV) in prenatal opioid exposure allow for investigation in the absence of confounding variables, such as clinical and social factors, that may influence outcomes across the lifespan in humans. Alongside the establishment of the impact of sex following prenatal opioid exposure, preclinical studies also lend themselves to the exploration of the mechanisms underlying sex-specific differences.</p><p>The effects of exogenous opioid administration in the developing central nervous system (CNS) begin with an understanding of the function of the endogenous opioid system in fetal development. Hauser and Knapp highlighted the modulation of cellular proliferation and differentiation by endogenous opioids that are context-dependent and vary by cell type, timing, and duration of exposure (<xref rid="B38" ref-type="bibr">38</xref>). Preclinical studies have shown the expression of mu-, delta- and kappa-opioid receptors in neural precursor cells. Expression of endogenous opioid peptides and receptors allows for proper coordination and timing of proliferation and differentiation in a region-specific manner during maturation and into adulthood allowing for plasticity (<xref rid="B38" ref-type="bibr">38</xref>). Endogenous opioid peptides are thought to function in the normal maturation process by inhibiting the growth of neural progenitor cells and allowing sufficient time for development to occur (<xref rid="B38" ref-type="bibr">38</xref>). Exogenous opioid exposure during this delicate maturational process may have a significant impact on the trajectory of the developing CNS. Several preclinical studies using cell cultures and animal models to examine oligodendrocyte maturation and function with exogenous opioid exposure during pregnancy demonstrate alterations in the timing of oligodendrocyte maturation and myelination (<xref rid="B39" ref-type="bibr">39</xref>). These studies further support emerging clinical literature that demonstrates white matter changes in infants with prenatal opioid exposure (<xref rid="B32" ref-type="bibr">32</xref>, <xref rid="B40" ref-type="bibr">40</xref>).</p><p>The interaction of sex on the endogenous opioid system has been further explored in the preclinical literature. In one study, cell culture models of rodent oligodendrocytes were evaluated postnatally to assess control of myelination and related processes by endogenous opioid peptide endomorphin at the mu-opioid receptor and opioid-related neuropeptide nociceptin at the nociceptin/orphanin receptor (<xref rid="B41" ref-type="bibr">41</xref>). The authors demonstrated an elegant interplay between endomorphin and nociceptin in regulating oligodendrocyte function and maturation restricted to those cells isolated from female pups (<xref rid="B41" ref-type="bibr">41</xref>). The suggestion of sex-specific effects on myelination controlled by the endogenous opioid system may have enduring ramifications for fetal brain development occurring in the context of exogenous opioid exposure.</p><p>Opioid receptor signaling and its role in regulating excitatory and inhibitory neural pathways by region is reviewed thoroughly by Reeves et al. demonstrating diversity in mechanisms of opioid-receptor mediated action (<xref rid="B42" ref-type="bibr">42</xref>). Hou et al. examined the impact of prenatal opioid exposure on opioid receptor signaling in mesolimbic structures in rodents during the neonatal period and found that male pups were particularly susceptible to aberrant signaling in this pathway following prenatal buprenorphine and methadone exposure (<xref rid="B43" ref-type="bibr">43</xref>). Altered excitatory and inhibitory synapses in the anterior cingulate cortex, nucleus accumbens, and prefrontal cortex of rodents exposed to exogenous morphine has also been noted (<xref rid="B44" ref-type="bibr">44</xref>). Further characterization of cell-specific roles and opioid receptor expression is necessary to gain a better understanding of the impact of endogenous and exogenous opioid signaling on brain circuitry.</p><p>Beyond neural cell-specific functions related to sex is the influence of sex-specific hormones. McCarthy et al. provided an elegant review of sex differentiation in rodent brains and behavior that stems from hormonal and chromosomal effects. Through an intricate intersection between neuroimmunity, neuroepigenetics, and neuroendocrine, sex-specific developmental programming takes place in the brain's innate immune cells, leading to unique neurodevelopment, phenotypic behaviors, and predisposition to neuropsychiatric disorders (<xref rid="B45" ref-type="bibr">45</xref>, <xref rid="B46" ref-type="bibr">46</xref>). The effects of sex hormones are also seen in the endogenous opioid system. Estrogen and progesterone regulate endogenous opioids via mu-opioid receptor activation and expression in signaling female reproductive behaviors in several rodent models (<xref rid="B47" ref-type="bibr">47</xref>, <xref rid="B48" ref-type="bibr">48</xref>). Similarly, androgens exert prenatal organization effects, responsible for the development of both internal and external sex organs, but more importantly, the sexual dimorphism of early brain development and subsequent behaviors throughout life (<xref rid="B49" ref-type="bibr">49</xref>). Sharp et al. provided a comprehensive review on sex differences in opioid-receptor mediated reward circuitry (<xref rid="B50" ref-type="bibr">50</xref>). Such sex differences likely determine distinct opioid-mediated dependence, sensitivity, tolerance, and withdrawal between males and females (<xref rid="B50" ref-type="bibr">50</xref>). Despite inconsistent findings across neuroanatomical regions and developmental stages due to complex regulatory roles inherent to the endogenous opioid system, sex-specific distinction exists in the amount and location of endogenous opioid receptors (mu-, delta-, and kappa-) and opioid peptides (beta-endorphin, met/leu-enkephalin, dynorphin). For instance, male rats have significantly greater concentrations of mu-opioid receptors in the spinal cord and midbrain than females, while females have significantly higher concentrations of kappa receptors in the spinal cord and hindbrain than males (<xref rid="B51" ref-type="bibr">51</xref>). Adult rat males had a greater abundance of beta endorphin in the prefrontal cortex than females, while adult females had a greater abundance of the same peptide in the hypothalamus, hippocampus, and anterior pituitary than males (<xref rid="B52" ref-type="bibr">52</xref>). The sex differences in endogenous opioid peptides and receptors are even more complex due to the fluctuation of these peptides and receptors over the course of the estrous cycle in females (<xref rid="B53" ref-type="bibr">53</xref>). Taken together, sex-specific differences in opioid receptor-mediated reward effects are complex and need to be accounted for in determining and understanding the effects of the opioid epidemic.</p><p>Preclinical literature examining the impact of exogenous opioid exposure during pregnancy on the hypothalamic-pituitary-adrenal (HPA) axis has also noted sex-specific differences in opioid-exposed adolescent and adult animals. One study demonstrates muted pituitary response to postnatal stress in adult female rodents following prenatal morphine exposure (<xref rid="B28" ref-type="bibr">28</xref>); another study suggests exaggerated pituitary response in adolescent males following prenatal oxycodone exposure (<xref rid="B54" ref-type="bibr">54</xref>). While these studies highlight sex-specific HPA dysregulation into adulthood following prenatal opioid exposure, further study of the impact of opioid type, duration of exposure, and underlying mechanisms, including receptor pathology, is needed.</p><p>There has been growing interest in the neural-gut connection and the role of the gut microbiome in pathology related to OUD (<xref rid="B36" ref-type="bibr">36</xref>, <xref rid="B37" ref-type="bibr">37</xref>). Antione et al. studied the impact of neonatal morphine exposure in mice and found gut dysbiosis and significant alterations in gut diversity and composition. Adolescent morphine-exposed females had increased Firmicutes/Bacteroidetes (F/B) ratio compared to saline-exposed females, while no differences were noted in morphine-exposed males compared to saline-exposed males (<xref rid="B35" ref-type="bibr">35</xref>). These changes in morphine-exposed females persisted into adulthood (<xref rid="B35" ref-type="bibr">35</xref>). Chronic methadone exposure in pregnant dams also showed alterations in gut microbiota in both dams and offspring, though no sex-specific differences were found (<xref rid="B55" ref-type="bibr">55</xref>). The neural-gut connection and its relation to developmental pathology following prenatal opioid exposure requires further investigation.</p><p>There are limited studies in preclinical models examining the influence of sex on long-term outcomes following prenatal opioid exposure. In an animal model of prenatal methadone exposure, Grecco et al. have shown limited sex-related differences in the early postnatal period, with more pronounced sex effects on alcohol reward behaviors in adolescence (<xref rid="B34" ref-type="bibr">34</xref>, <xref rid="B56" ref-type="bibr">56</xref>). Methadone-exposed females showed a greater preference for alcohol-associated environments, whereas methadone-exposed males demonstrated resistance to this conditioned preference (<xref rid="B56" ref-type="bibr">56</xref>). There were also differences in behavior responses to alcohol, with methadone-exposed adolescent females showing hyperactivity and increased locomotor activity following alcohol consumption and methadone-exposed males demonstrating more binge-like alcohol consumption (<xref rid="B56" ref-type="bibr">56</xref>). Interestingly, examination of mu-opioid receptor density in the reward pathway of adult rodents following prenatal morphine exposure demonstrates a significantly greater increase in mu-opioid receptor density in males compared to females (<xref rid="B57" ref-type="bibr">57</xref>). Morphine-exposed males were more vulnerable to executive function deficits tested in adulthood, evidenced by impaired learning, motivation, and attention (<xref rid="B58" ref-type="bibr">58</xref>). Further examination of sex differences in microglia and synaptic pruning pathways suggested deficits in microglial phagocytic pathways in male offspring with morphine exposure may underly these enduring behavioral impairments (<xref rid="B58" ref-type="bibr">58</xref>). These studies highlight the importance of understanding the developmental crosstalk between sex and prenatal opioid exposure and its influence on neuronal functioning, reward pathway signaling, and behavior into adulthood.</p></sec><sec id="s2b"><label>2.2</label><title>Sex differences in OUD</title><p>Paralleling the preclinical data, sex-specific effects of opioids are also evident in adults with OUD. With almost 11 million Americans reporting opioid misuse in 2016, the prevalence of OUD remains highest in males, however, the rate of use increases more rapidly in females (<xref rid="B59" ref-type="bibr">59</xref>). The risk of overdose is also higher in males, but emerging data highlight distinct vulnerabilities in females, especially during pregnancy and the postpartum period (<xref rid="B60" ref-type="bibr">60</xref>, <xref rid="B61" ref-type="bibr">61</xref>).</p><p>A scoping review by Huhn et al. demonstrated several themes across the addiction cycle that were different between males and females (<xref rid="B62" ref-type="bibr">62</xref>). Although most studies were retrospective and not powered to assess sex differences, the authors reported a significantly higher burden of mental health disorders, particularly depression and suicidal ideation, in females compared to males at the time of presentation for treatment (<xref rid="B62" ref-type="bibr">62</xref>). Co-occurring mental illness, i.e., depression, in females conferred a unique risk for relapse (<xref rid="B62" ref-type="bibr">62</xref>). These findings underscore the need for addressing comorbid mental health conditions in treatment programs for OUD and tailoring these approaches to females. Several studies promoted the use of buprenorphine treatment for females as it was associated with lower rates of relapse and higher rates of treatment retention compared to males with OUD (<xref rid="B62" ref-type="bibr">62</xref>). Overall, this review identifies important themes to help inform and tailor practice strategies and highlights the need for additional prospective studies and further understanding of the biological mechanism underlying sex-related differences in the treatment of OUD. The same authors have published a systematic review of preclinical literature evaluating sex-related differences in response to endogenous and exogenous opioids, which further highlights the need for more rigorous study in this area (<xref rid="B63" ref-type="bibr">63</xref>).</p><p>Another study by Davis and colleagues used machine learning to assess multi-center follow-up data to evaluate sex differences in factors predicting relapse following treatment of OUD (<xref rid="B64" ref-type="bibr">64</xref>). Younger age at initiation and male sex were risk factors for relapse. Conduct disorder and multiple co-occurring substance use disorders posed a greater risk for return to opioid use in males (<xref rid="B64" ref-type="bibr">64</xref>). For females, withdrawal symptoms, depressive symptoms, and diagnosis of post-traumatic stress disorder were factors that increased the likelihood of relapse following treatment (<xref rid="B64" ref-type="bibr">64</xref>). Understanding sex differences in risk factors for relapse following OUD treatment may inform personalized treatment programs to mitigate such risks and, in turn, tackle the growing opioid epidemic. More rigorous clinical data from prospective studies designed to assess sex differences in OUD management and outcomes are urgently needed.</p></sec><sec id="s2c"><label>2.3</label><title>Sex differences in neonates with prenatal opioid exposure and clinical outcomes</title><p>NAS manifests as multiorgan withdrawal signs, e.g., high-pitch cries, tremors, hypertonia, difficulty feeding, hyperphagia, sleep disturbance, loose stools, and poor growth. Some neonates have more severe withdrawal requiring pharmacotherapy with unclear risk factors. Maternal factors (medication types, dose, comorbid physical and mental health conditions, polysubstance use, socioeconomic status), neonatal factors (gestational age, body weight), hospital-based practice variations, and genetic and epigenetic factors may contribute to specific risk profiles and predisposition to worse NAS (<xref rid="B65" ref-type="bibr">65</xref>&#8211;<xref rid="B70" ref-type="bibr">70</xref>). Opioid-exposed males and females may also exhibit different responses and clinical outcomes related to <italic toggle="yes">in utero</italic> opioid exposure. Data on sex differences in the risk, clinical presentations, and need for pharmacotherapy in opioid-exposed neonates remain unclear. Some reported no sex differences in the withdrawal severity, need for pharmacotherapy, and duration of treatment for NAS (<xref rid="B14" ref-type="bibr">14</xref>, <xref rid="B15" ref-type="bibr">15</xref>). Others showed that male sex is a risk factor for worse withdrawal and need for pharmacotherapy, and female sex is protective against severe withdrawal (<xref rid="B10" ref-type="bibr">10</xref>, <xref rid="B11" ref-type="bibr">11</xref>, <xref rid="B71" ref-type="bibr">71</xref>, <xref rid="B72" ref-type="bibr">72</xref>).</p><p>Conradt et al. showed that of the 52 studies on long-term outcomes in opioid-exposed neonates published between 1975 and 2019, only 18 were published in the last five years, pointing to the lack of longitudinal studies in the field (<xref rid="B73" ref-type="bibr">73</xref>). Opioid-exposed children seemed to exhibit more adverse behaviors, e.g., anxiety, aggression, fear, and have lower executive functioning, with more ambiguity in cognitive outcomes. Only two of these 18 studies were prospective, highlighting the tremendous challenge in understanding long-term outcomes in opioid-exposed neonates. Several critical methodologic shortcomings thought to contribute to such challenges were the small sample size, the abundance of confounding factors, the lack of consensus on the assessment and diagnosis of NAS, and the lack of early biomarkers to track risks and neurodevelopmental outcomes. Furthermore, less than half of these publications considered sex differences (<xref rid="B73" ref-type="bibr">73</xref>). Consequently, the sex-specific impact of prenatal opioid exposure remains unclear, with some reported males having poorer cognitive and language development in early childhood (<xref rid="B74" ref-type="bibr">74</xref>), another showing both sexes performing worse on cognitive functioning than their respective non-exposed counterparts, yet another reporting females having worse and increasing differences in cognitive at a later age (<xref rid="B27" ref-type="bibr">27</xref>).</p><p>Emerging studies have focused on biomarker research in NAS. Biomarker discovery has the potential to provide a mechanistic underpinning of NAS, which can inform targeted interventions and convenient monitoring for this condition (<xref rid="B70" ref-type="bibr">70</xref>). Existing studies demonstrated that genetic and epigenetic changes may predict withdrawal severity and the need for pharmacotherapy. These changes include variants of the cytochrome P450 family 2 subfamily B member 6 (<italic toggle="yes">CYP2B6</italic>) (<xref rid="B75" ref-type="bibr">75</xref>), increased methylation of ATP binding cassette subfamily B member 1 (<italic toggle="yes">ABCB1</italic>)<italic toggle="yes">,</italic> cytochrome P450 family 2 subfamily D member 6 (<italic toggle="yes">CYP2D6</italic>)<italic toggle="yes">,</italic> and opioid receptor mu 1 (<italic toggle="yes">OPRM1</italic>) (<xref rid="B76" ref-type="bibr">76</xref>, <xref rid="B77" ref-type="bibr">77</xref>), single nucleotide polymorphism in opioid receptor kappa 1 (<italic toggle="yes">OPRK1</italic>), opioid receptor delta 1 (<italic toggle="yes">OPRD1</italic>), prepronociceptin (<italic toggle="yes">PNOC</italic>) (<xref rid="B78" ref-type="bibr">78</xref>), and dopamine receptor type 2 (<italic toggle="yes">DRD2</italic>) (<xref rid="B79" ref-type="bibr">79</xref>). The first genome-wide association studies done in opioid-exposed neonates showed a promising potential to develop a polygenic risk score that can predict the need for pharmacotherapy (<xref rid="B80" ref-type="bibr">80</xref>). Camerota et al. showed that pharmacotherapy for NAS decreased DNA methylation in one of four CpG sites within the <italic toggle="yes">OPRM1 and was</italic> accompanied by improved clinical presentations, e.g., reduced irritability, signs of stress, and abnormal movements (<xref rid="B81" ref-type="bibr">81</xref>), suggesting the utility of biomarkers in monitoring disease progression in NAS. Similar to the trend in the clinical studies, however, only a few molecular studies considered sex differences.</p><p>Sex-specific mechanisms commence long before birth and stem from an intricate gestational interplay between the mother and the fetus, between the chromosomal and hormonal effects, resulting in distinct neurobehavioral changes and sex-specific vulnerability (<xref rid="B17" ref-type="bibr">17</xref>, <xref rid="B82" ref-type="bibr">82</xref>, <xref rid="B83" ref-type="bibr">83</xref>) (<xref rid="F1" ref-type="fig">Figure&#160;1</xref>). Maternal factors (e.g., drug metabolism and immune responses) affect placental gene expression. At the same time, fetal sex also modulates placental gene transcription. Testosterone release by male fetuses in mid to late gestation differentiates the body and the brain from females, which further impacts the physiological responses and drug metabolism after birth. In addition to this hormonal effect, the sex chromosome-specific genes modulate sex-specific responses, furthering the sex-specific differences pre and postnatally (<xref rid="B82" ref-type="bibr">82</xref>). Converging data support the propensity of male fetuses to early-life adverse events and the greater vulnerability to subsequent developmental challenges (<xref rid="B17" ref-type="bibr">17</xref>, <xref rid="B26" ref-type="bibr">26</xref>). Therefore, sexual dimorphism related to prenatal opioid exposure will affect the postnatal course, supporting the need to study sex differences to optimize care.</p><p>A few studies have demonstrated evidence of molecular mechanisms underlying sex-specific changes in NAS. A salivary transcriptomic study showed that opioid-exposed males had greater expression of key reward gene <italic toggle="yes">DRD2</italic> than opioid-exposed females. This sex-differential gene expression persisted with the need for pharmacotherapy and correlated positively with volume of oral intake (breastmilk, formula), suggesting sex-specific aberrant reward signaling might predispose males to worse NAS (<xref rid="B31" ref-type="bibr">31</xref>). Opioid-exposed females, however, are not without risks. Despite less severe overt withdrawal, exposed females had a greater incidence of white matter hyperintensity in brain imaging than exposed males (<xref rid="B32" ref-type="bibr">32</xref>). Such white matter hyperintensity findings were accompanied by greater expression of proinflammatory genes, suggesting sex-specific proinflammatory effects of prenatal opioids and associated brain injury with a greater effect in females than males (<xref rid="B32" ref-type="bibr">32</xref>). Sex-specific proinflammatory effects on the brain and feeding regulation may alter the brain-gut axis and long-term health and developmental outcomes.</p><p>Sex-specific differences in dopamine receptor gene expression implicate the disruption of mesolimbic and mesocortical dopamine pathways in neonates with prenatal opioid exposure. Postnatal neuroimaging in opioid-exposed neonates demonstrated smaller deep gray matter structures (e.g., ventrolateral thalami, subthalamic nuclei) and smaller brainstem volumes adding to the evidence of alterations in these dopaminergic pathways (<xref rid="B84" ref-type="bibr">84</xref>). Resting-state functional imaging demonstrates global connectivity issues in neonates with prenatal opioid exposure, suggesting the involvement of various pathways and regions in aberrations related to opioid exposure (<xref rid="B85" ref-type="bibr">85</xref>). These small cohort studies have controlled for sex but were not designed to show sex differences, necessitating further investigation.</p><p>Clinical and molecular studies in neonates with prenatal opioid exposure may be essential first steps to understanding sex-specific risks and vulnerability differences in adults with OUD. Prenatal opioid exposure imposes myriad health challenges, including structural and functional brain changes, cognitive and neurodevelopment, vision health, and nutrition and growth (<xref rid="B73" ref-type="bibr">73</xref>, <xref rid="B84" ref-type="bibr">84</xref>, <xref rid="B86" ref-type="bibr">86</xref>&#8211;<xref rid="B90" ref-type="bibr">90</xref>). Accounting for sex is crucial to understanding opioid effects and targeting efforts and interventions to prevent, cure, and ameliorate such effects. Males and females have fundamental differences that cannot be simplified or ignored, and we must meticulously study these unique characteristics to provide optimal care for this vulnerable population.</p></sec></sec><sec id="s3"><label>3</label><title>Conclusion/future directions</title><p>The present narrative review of preclinical and clinical literature reveals several salient sex-related differences in neonates, children, and adults affected by OUD and underscores the need to include SABV in future investigations. Preclinical studies with particular attention to the unique interplay between the endogenous opioid system and coordination of neural maturation and differentiation, alongside neuroendocrine effects specific to sex hormone biology, may be particularly informative in understanding the impact of prenatal opioid exposure. Future studies should focus on the sex-specific and proinflammatory impact of prenatal opioid exposure on the placenta-brain, placenta-gut, and brain-gut axes as they may elucidate novel biomarkers and treatment strategies. While there is significant biological plausibility underlying the influence of sex on prenatal opioid exposure and neonatal outcomes, a more substantial investigation into the sex-specific mechanisms underlying this developmental influence is imperative to inform the identification and management of neonates at risk for NAS. Understanding the full scope of the impact of opioid use and misuse on fetal development, neonatal, and adult outcomes is a daunting prospect, but the influence of sex in each of these pathways is an essential consideration and must not be overlooked.</p></sec></body><back><sec sec-type="author-contributions" id="s4"><title>Author contributions</title><p>NM: Writing &#8211; review &amp; editing, Writing &#8211; original draft, Methodology, Investigation, Formal Analysis, Conceptualization. LJ: Writing &#8211; review &amp; editing, Writing &#8211; original draft, Methodology, Investigation, Funding acquisition, Formal Analysis. EY: Writing &#8211; review &amp; editing, Writing &#8211; original draft, Supervision, Project administration, Methodology, Investigation, Funding acquisition, Formal Analysis, Conceptualization.</p></sec><sec sec-type="COI-statement" id="s6"><title>Conflict of interest</title><p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec><sec sec-type="disclaimer" id="s7"><title>Publisher's note</title><p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p></sec><ref-list><title>References</title><ref id="B1"><label>1.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Desai</surname><given-names>RJ</given-names></name><name name-style="western"><surname>Hernandez-Diaz</surname><given-names>S</given-names></name><name name-style="western"><surname>Bateman</surname><given-names>BT</given-names></name><name name-style="western"><surname>Huybrechts</surname><given-names>KF</given-names></name></person-group>. <article-title>Increase in prescription opioid use during pregnancy among medicaid-enrolled women</article-title>. <source>Obstet Gynecol</source>. (<year>2014</year>) <volume>123</volume>(<issue>5</issue>):<fpage>997</fpage>&#8211;<lpage>1002</lpage>. <pub-id pub-id-type="doi">10.1097/AOG.0000000000000208</pub-id><pub-id pub-id-type="pmid">24785852</pub-id><pub-id pub-id-type="pmcid">PMC4020039</pub-id></mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tolia</surname><given-names>VN</given-names></name><name name-style="western"><surname>Patrick</surname><given-names>SW</given-names></name><name name-style="western"><surname>Bennett</surname><given-names>MM</given-names></name><name name-style="western"><surname>Murthy</surname><given-names>K</given-names></name><name name-style="western"><surname>Sousa</surname><given-names>J</given-names></name><name name-style="western"><surname>Smith</surname><given-names>PB</given-names></name><etal/></person-group><article-title>Increasing incidence of the neonatal abstinence syndrome in U. S. neonatal ICUs</article-title>. <source>N Engl J Med</source>. (<year>2015</year>) <volume>372</volume>(<issue>22</issue>):<fpage>2118</fpage>&#8211;<lpage>26</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMsa1500439</pub-id><pub-id pub-id-type="pmid">25913111</pub-id></mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Winkelman</surname><given-names>TNA</given-names></name><name name-style="western"><surname>Villapiano</surname><given-names>N</given-names></name><name name-style="western"><surname>Kozhimannil</surname><given-names>KB</given-names></name><name name-style="western"><surname>Davis</surname><given-names>MM</given-names></name><name name-style="western"><surname>Patrick</surname><given-names>SW</given-names></name></person-group>. <article-title>Incidence and costs of neonatal abstinence syndrome among infants with medicaid: 2004&#8211;2014</article-title>. <source>Pediatrics</source>. (<year>2018</year>) <volume>141</volume>(<issue>4</issue>):<fpage>1</fpage>&#8211;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1542/peds.2017-3520</pub-id><pub-id pub-id-type="pmcid">PMC5869343</pub-id><pub-id pub-id-type="pmid">29572288</pub-id></mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hirai</surname><given-names>AH</given-names></name><name name-style="western"><surname>Ko</surname><given-names>JY</given-names></name><name name-style="western"><surname>Owens</surname><given-names>PL</given-names></name><name name-style="western"><surname>Stocks</surname><given-names>C</given-names></name><name name-style="western"><surname>Patrick</surname><given-names>SW</given-names></name></person-group>. <article-title>Neonatal abstinence syndrome and maternal opioid-related diagnoses in the US, 2010&#8211;2017</article-title>. <source>JAMA</source>. (<year>2021</year>) <volume>325</volume>(<issue>2</issue>):<fpage>146</fpage>. <pub-id pub-id-type="doi">10.1001/jama.2020.24991</pub-id><pub-id pub-id-type="pmid">33433576</pub-id><pub-id pub-id-type="pmcid">PMC7804920</pub-id></mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ko</surname><given-names>JY</given-names></name><name name-style="western"><surname>Patrick</surname><given-names>SW</given-names></name><name name-style="western"><surname>Tong</surname><given-names>VT</given-names></name><name name-style="western"><surname>Patel</surname><given-names>R</given-names></name><name name-style="western"><surname>Lind</surname><given-names>JN</given-names></name><name name-style="western"><surname>Barfield</surname><given-names>WD</given-names></name></person-group>. <article-title>Incidence of neonatal abstinence syndrome&#8212;28 states, 1999&#8211;2013</article-title>. <source>MMWR Morb Mortal Wkly Rep</source>. (<year>2016</year>) <volume>65</volume>(<issue>31</issue>):<fpage>799</fpage>&#8211;<lpage>802</lpage>. <pub-id pub-id-type="doi">10.15585/mmwr.mm6531a2</pub-id><pub-id pub-id-type="pmid">27513154</pub-id></mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Villapiano</surname><given-names>NLG</given-names></name><name name-style="western"><surname>Winkelman</surname><given-names>TNA</given-names></name><name name-style="western"><surname>Kozhimannil</surname><given-names>KB</given-names></name><name name-style="western"><surname>Davis</surname><given-names>MM</given-names></name><name name-style="western"><surname>Patrick</surname><given-names>SW</given-names></name></person-group>. <article-title>Rural and urban differences in neonatal abstinence syndrome and maternal opioid use, 2004 to 2013</article-title>. <source>JAMA Pediatr</source>. (<year>2017</year>) <volume>171</volume>(<issue>2</issue>):<fpage>194</fpage>. <pub-id pub-id-type="doi">10.1001/jamapediatrics.2016.3750</pub-id><pub-id pub-id-type="pmid">27942711</pub-id></mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Patrick</surname><given-names>SW</given-names></name><name name-style="western"><surname>Schumacher</surname><given-names>RE</given-names></name><name name-style="western"><surname>Benneyworth</surname><given-names>BD</given-names></name><name name-style="western"><surname>Krans</surname><given-names>EE</given-names></name><name name-style="western"><surname>McAllister</surname><given-names>JM</given-names></name><name name-style="western"><surname>Davis</surname><given-names>MM</given-names></name></person-group>. <article-title>Neonatal abstinence syndrome and associated health care expenditures</article-title>. <source>JAMA</source>. (<year>2012</year>) <volume>307</volume>(<issue>18</issue>):<fpage>1934</fpage>&#8211;<lpage>40</lpage>. <pub-id pub-id-type="doi">10.1001/jama.2012.3951</pub-id><pub-id pub-id-type="pmid">22546608</pub-id></mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Patrick</surname><given-names>SW</given-names></name><name name-style="western"><surname>Barfield</surname><given-names>WD</given-names></name><name name-style="western"><surname>Poindexter</surname><given-names>BB</given-names></name><name name-style="western"><surname>Cummings</surname><given-names>J</given-names></name><name name-style="western"><surname>Hand</surname><given-names>I</given-names></name><name name-style="western"><surname>Adams-Chapman</surname><given-names>I</given-names></name><etal/></person-group><article-title>Neonatal opioid withdrawal syndrome</article-title>. <source>Pediatrics</source>. (<year>2020</year>) <volume>146</volume>(<issue>5</issue>):<fpage>1</fpage>&#8211;<lpage>18</lpage>. <pub-id pub-id-type="doi">10.1542/peds.2020-029074</pub-id><pub-id pub-id-type="pmid">33106341</pub-id></mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Patrick</surname><given-names>SW</given-names></name><name name-style="western"><surname>Dudley</surname><given-names>J</given-names></name><name name-style="western"><surname>Martin</surname><given-names>PR</given-names></name><name name-style="western"><surname>Harrell</surname><given-names>FE</given-names></name><name name-style="western"><surname>Warren</surname><given-names>MD</given-names></name><name name-style="western"><surname>Hartmann</surname><given-names>KE</given-names></name><etal/></person-group><article-title>Prescription opioid epidemic and infant outcomes</article-title>. <source>Pediatrics</source>. (<year>2015</year>) <volume>135</volume>(<issue>5</issue>):<fpage>842</fpage>&#8211;<lpage>50</lpage>. <pub-id pub-id-type="doi">10.1542/peds.2014-3299</pub-id><pub-id pub-id-type="pmid">25869370</pub-id><pub-id pub-id-type="pmcid">PMC4411781</pub-id></mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jansson</surname><given-names>LM</given-names></name><name name-style="western"><surname>DiPietro</surname><given-names>JA</given-names></name><name name-style="western"><surname>Elko</surname><given-names>A</given-names></name><name name-style="western"><surname>Velez</surname><given-names>M</given-names></name></person-group>. <article-title>Infant autonomic functioning and neonatal abstinence syndrome</article-title>. <source>Drug Alcohol Depend</source>. (<year>2010</year>) <volume>109</volume>(<issue>1&#8211;3</issue>):<fpage>198</fpage>&#8211;<lpage>204</lpage>. <pub-id pub-id-type="doi">10.1016/j.drugalcdep.2010.01.004</pub-id><pub-id pub-id-type="pmid">20189732</pub-id><pub-id pub-id-type="pmcid">PMC2875284</pub-id></mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Charles</surname><given-names>MK</given-names></name><name name-style="western"><surname>Cooper</surname><given-names>WO</given-names></name><name name-style="western"><surname>Jansson</surname><given-names>LM</given-names></name><name name-style="western"><surname>Dudley</surname><given-names>J</given-names></name><name name-style="western"><surname>Slaughter</surname><given-names>JC</given-names></name><name name-style="western"><surname>Patrick</surname><given-names>SW</given-names></name></person-group>. <article-title>Male sex associated with increased risk of neonatal abstinence syndrome</article-title>. <source>Hosp Pediatr</source>. (<year>2017</year>) <volume>7</volume>(<issue>6</issue>):<fpage>328</fpage>&#8211;<lpage>34</lpage>. <pub-id pub-id-type="doi">10.1542/hpeds.2016-0218</pub-id><pub-id pub-id-type="pmid">28465360</pub-id><pub-id pub-id-type="pmcid">PMC5519405</pub-id></mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jansson</surname><given-names>LM</given-names></name><name name-style="western"><surname>Dipietro</surname><given-names>JA</given-names></name><name name-style="western"><surname>Elko</surname><given-names>A</given-names></name><name name-style="western"><surname>Velez</surname><given-names>M</given-names></name></person-group>. <article-title>Maternal vagal tone change in response to methadone is associated with neonatal abstinence syndrome severity in exposed neonates</article-title>. <source>J Matern Fetal Neonatal Med</source>. (<year>2007</year>) <volume>20</volume>(<issue>9</issue>):<fpage>677</fpage>&#8211;<lpage>85</lpage>. <pub-id pub-id-type="doi">10.1080/14767050701490327</pub-id><pub-id pub-id-type="pmid">17701668</pub-id></mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>O&#8217;Connor</surname><given-names>AB</given-names></name><name name-style="western"><surname>O&#8217;Brien</surname><given-names>L</given-names></name><name name-style="western"><surname>Alto</surname><given-names>WA</given-names></name></person-group>. <article-title>Maternal buprenorphine dose at delivery and its relationship to neonatal outcomes</article-title>. <source>Eur Addict Res</source>. (<year>2016</year>) <volume>22</volume>(<issue>3</issue>):<fpage>127</fpage>&#8211;<lpage>30</lpage>. <pub-id pub-id-type="doi">10.1159/000441220</pub-id><pub-id pub-id-type="pmid">26491960</pub-id></mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Holbrook</surname><given-names>A</given-names></name><name name-style="western"><surname>Kaltenbach</surname><given-names>K</given-names></name></person-group>. <article-title>Gender and NAS: does sex matter?</article-title><source>Drug Alcohol Depend</source>. (<year>2010</year>) <volume>112</volume>(<issue>1&#8211;2</issue>):<fpage>156</fpage>&#8211;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/j.drugalcdep.2010.05.015</pub-id><pub-id pub-id-type="pmid">20576365</pub-id></mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Unger</surname><given-names>A</given-names></name><name name-style="western"><surname>Jagsch</surname><given-names>R</given-names></name><name name-style="western"><surname>B&#228;wert</surname><given-names>A</given-names></name><name name-style="western"><surname>Winklbaur</surname><given-names>B</given-names></name><name name-style="western"><surname>Rohrmeister</surname><given-names>K</given-names></name><name name-style="western"><surname>Martin</surname><given-names>PR</given-names></name><etal/></person-group><article-title>Are male neonates more vulnerable to neonatal abstinence syndrome than female neonates?</article-title><source>Gend Med</source>. (<year>2011</year>) <volume>8</volume>(<issue>6</issue>):<fpage>355</fpage>&#8211;<lpage>64</lpage>. <pub-id pub-id-type="doi">10.1016/j.genm.2011.10.001</pub-id><pub-id pub-id-type="pmid">22088886</pub-id><pub-id pub-id-type="pmcid">PMC3241965</pub-id></mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pinn</surname><given-names>VW</given-names></name></person-group>. <article-title>Sex and gender factors in medical studies</article-title>. <source>JAMA</source>. (<year>2003</year>) <volume>289</volume>(<issue>4</issue>):<fpage>397</fpage>. <pub-id pub-id-type="doi">10.1001/jama.289.4.397</pub-id><pub-id pub-id-type="pmid">12533102</pub-id></mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>DiPietro</surname><given-names>JA</given-names></name><name name-style="western"><surname>Voegtline</surname><given-names>KM</given-names></name></person-group>. <article-title>The gestational foundation of sex differences in development and vulnerability</article-title>. <source>Neuroscience</source>. (<year>2017</year>) <volume>342</volume>:<fpage>4</fpage>&#8211;<lpage>20</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroscience.2015.07.068</pub-id><pub-id pub-id-type="pmid">26232714</pub-id><pub-id pub-id-type="pmcid">PMC4732938</pub-id></mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bake</surname><given-names>S</given-names></name><name name-style="western"><surname>Rouzer</surname><given-names>SK</given-names></name><name name-style="western"><surname>Mavuri</surname><given-names>S</given-names></name><name name-style="western"><surname>Miranda</surname><given-names>RC</given-names></name><name name-style="western"><surname>Mahnke</surname><given-names>AH</given-names></name></person-group>. <article-title>The interaction of genetic sex and prenatal alcohol exposure on health across the lifespan</article-title>. <source>Front Neuroendocrinol</source>. (<year>2023</year>) <volume>71</volume>:<fpage>101103</fpage>. <pub-id pub-id-type="doi">10.1016/j.yfrne.2023.101103</pub-id><pub-id pub-id-type="pmid">37802472</pub-id><pub-id pub-id-type="pmcid">PMC10922031</pub-id></mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kirchengast</surname><given-names>S</given-names></name><name name-style="western"><surname>Hartmann</surname><given-names>B</given-names></name></person-group>. <article-title>The male disadvantage hypothesis reconsidered: is there really a weaker sex? An analysis of gender differences in newborn somatometrics and vital parameters</article-title>. <source>J Life Sci</source>. (<year>2009</year>) <volume>1</volume>(<issue>1</issue>):<fpage>63</fpage>&#8211;<lpage>71</lpage>. .24611315
</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bekedam</surname><given-names>DJ</given-names></name><name name-style="western"><surname>Engelsbel</surname><given-names>S</given-names></name><name name-style="western"><surname>Mol</surname><given-names>BWJ</given-names></name><name name-style="western"><surname>Buitendijk</surname><given-names>SE</given-names></name><name name-style="western"><surname>van der Pal-de Bruin</surname><given-names>KM</given-names></name></person-group>. <article-title>Male predominance in fetal distress during labor</article-title>. <source>Am J Obstet Gynecol</source>. (<year>2002</year>) <volume>187</volume>(<issue>6</issue>):<fpage>1605</fpage>&#8211;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1067/mob.2002.127379</pub-id><pub-id pub-id-type="pmid">12501071</pub-id></mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sheiner</surname><given-names>E</given-names></name><name name-style="western"><surname>Hadar</surname><given-names>A</given-names></name><name name-style="western"><surname>Hallak</surname><given-names>M</given-names></name><name name-style="western"><surname>Katz</surname><given-names>M</given-names></name><name name-style="western"><surname>Mazor</surname><given-names>M</given-names></name><name name-style="western"><surname>Shoham-Vardi</surname><given-names>I</given-names></name></person-group>. <article-title>Clinical significance of fetal heart rate tracings during the second stage of labor</article-title>. <source>Obstet Gynecol</source>. (<year>2001</year>) <volume>97</volume>(<issue>5</issue>):<fpage>747</fpage>&#8211;<lpage>52</lpage>. <pub-id pub-id-type="doi">10.1016/s0029-7844(01)01188-7</pub-id><pub-id pub-id-type="pmid">11339928</pub-id></mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nagy</surname><given-names>E</given-names></name><name name-style="western"><surname>Loveland</surname><given-names>KA</given-names></name><name name-style="western"><surname>Orvos</surname><given-names>H</given-names></name><name name-style="western"><surname>Moln&#225;r</surname><given-names>P</given-names></name></person-group>. <article-title>Gender-related physiologic differences in human neonates and the greater vulnerability of males to developmental brain disorders</article-title>. <source>J Gend Specif Med</source>. (<year>2001</year>) <volume>4</volume>(<issue>1</issue>):<fpage>41</fpage>&#8211;<lpage>9</lpage>. .<pub-id pub-id-type="pmid">11324239</pub-id></mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Weinberg</surname><given-names>MK</given-names></name><name name-style="western"><surname>Tronick</surname><given-names>EZ</given-names></name><name name-style="western"><surname>Cohn</surname><given-names>JF</given-names></name><name name-style="western"><surname>Olson</surname><given-names>KL</given-names></name></person-group>. <article-title>Gender differences in emotional expressivity and self-regulation during early infancy</article-title>. <source>Dev Psychol</source>. (<year>1999</year>) <volume>35</volume>(<issue>1</issue>):<fpage>175</fpage>&#8211;<lpage>88</lpage>. <pub-id pub-id-type="doi">10.1037/0012-1649.35.1.175</pub-id><pub-id pub-id-type="pmid">9923473</pub-id></mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Eogan</surname><given-names>MA</given-names></name></person-group>. <article-title>Effect of fetal sex on labour and delivery: retrospective review</article-title>. <source>Br Med J</source>. (<year>2003</year>) <volume>326</volume>(<issue>7381</issue>):<fpage>137</fpage>&#8211;<lpage>137</lpage>. <pub-id pub-id-type="doi">10.1136/bmj.326.7381.137</pub-id><pub-id pub-id-type="pmid">12531846</pub-id><pub-id pub-id-type="pmcid">PMC140006</pub-id></mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ingemarsson</surname><given-names>I</given-names></name></person-group>. <article-title>Gender aspects of preterm birth</article-title>. <source>BJOG</source>. (<year>2003</year>) <volume>110</volume>:<fpage>34</fpage>&#8211;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1046/j.1471-0528.2003.00022.x</pub-id><pub-id pub-id-type="pmid">12763109</pub-id></mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chalak</surname><given-names>LF</given-names></name><name name-style="western"><surname>Pruszynski</surname><given-names>JE</given-names></name><name name-style="western"><surname>Spong</surname><given-names>CY</given-names></name></person-group>. <article-title>Sex vulnerabilities to hypoxia-ischemia at birth</article-title>. <source>JAMA Netw Open</source>. (<year>2023</year>) <volume>6</volume>(<issue>8</issue>):<fpage>e2326542</fpage>. <pub-id pub-id-type="doi">10.1001/jamanetworkopen.2023.26542</pub-id><pub-id pub-id-type="pmid">37526938</pub-id><pub-id pub-id-type="pmcid">PMC10394577</pub-id></mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Skumlien</surname><given-names>M</given-names></name><name name-style="western"><surname>Ibsen</surname><given-names>IO</given-names></name><name name-style="western"><surname>Kesmodel</surname><given-names>US</given-names></name><name name-style="western"><surname>Nygaard</surname><given-names>E</given-names></name></person-group>. <article-title>Sex differences in early cognitive development after prenatal exposure to opioids</article-title>. <source>J Pediatr Psychol</source>. (<year>2020</year>) <volume>45</volume>(<issue>5</issue>):<fpage>475</fpage>&#8211;<lpage>85</lpage>. <pub-id pub-id-type="doi">10.1093/jpepsy/jsaa008</pub-id><pub-id pub-id-type="pmid">32324876</pub-id><pub-id pub-id-type="pmcid">PMC7233842</pub-id></mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>&#352;lamberov&#225;</surname><given-names>R</given-names></name><name name-style="western"><surname>Riman&#243;czy</surname><given-names>&#193;</given-names></name><name name-style="western"><surname>Riley</surname><given-names>MA</given-names></name><name name-style="western"><surname>Vathy</surname><given-names>I</given-names></name></person-group>. <article-title>Hypothalamo-pituitary-adrenal axis-regulated stress response and negative feedback sensitivity is altered by prenatal morphine exposure in adult female rats</article-title>. <source>Neuroendocrinology</source>. (<year>2004</year>) <volume>80</volume>(<issue>3</issue>):<fpage>192</fpage>&#8211;<lpage>200</lpage>. <pub-id pub-id-type="doi">10.1159/000082359</pub-id><pub-id pub-id-type="pmid">15583475</pub-id></mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Madurai</surname><given-names>NK</given-names></name><name name-style="western"><surname>Kitase</surname><given-names>Y</given-names></name><name name-style="western"><surname>Hamimi</surname><given-names>S</given-names></name><name name-style="western"><surname>Kirk</surname><given-names>SE</given-names></name><name name-style="western"><surname>Sevensky</surname><given-names>R</given-names></name><name name-style="western"><surname>Ramachandra</surname><given-names>S</given-names></name><etal/></person-group><article-title>Methadone alters the peripheral inflammatory and central immune landscape following prenatal exposure in rats</article-title>. <source>Adv Drug Alcohol Res</source>. (<year>2022</year>) <volume>2</volume>:<fpage>1</fpage>&#8211;<lpage>13</lpage>. <pub-id pub-id-type="doi">10.3389/adar.2022.10792</pub-id><pub-id pub-id-type="pmcid">PMC10312988</pub-id><pub-id pub-id-type="pmid">37396628</pub-id></mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jantzie</surname><given-names>LL</given-names></name><name name-style="western"><surname>Maxwell</surname><given-names>JR</given-names></name><name name-style="western"><surname>Newville</surname><given-names>JC</given-names></name><name name-style="western"><surname>Yellowhair</surname><given-names>TR</given-names></name><name name-style="western"><surname>Kitase</surname><given-names>Y</given-names></name><name name-style="western"><surname>Madurai</surname><given-names>N</given-names></name><etal/></person-group><article-title>Prenatal opioid exposure: the next neonatal neuroinflammatory disease</article-title>. <source>Brain Behav Immun</source>. (<year>2020</year>) <volume>84</volume>:<fpage>45</fpage>&#8211;<lpage>58</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbi.2019.11.007</pub-id><pub-id pub-id-type="pmid">31765790</pub-id><pub-id pub-id-type="pmcid">PMC7010550</pub-id></mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yen</surname><given-names>E</given-names></name><name name-style="western"><surname>Kaneko-Tarui</surname><given-names>T</given-names></name><name name-style="western"><surname>Ruthazer</surname><given-names>R</given-names></name><name name-style="western"><surname>Harvey-Wilkes</surname><given-names>K</given-names></name><name name-style="western"><surname>Hassaneen</surname><given-names>M</given-names></name><name name-style="western"><surname>Maron</surname><given-names>JL</given-names></name></person-group>. <article-title>Sex-dependent gene expression in infants with neonatal opioid withdrawal syndrome</article-title>. <source>J Pediatr</source>. (<year>2019</year>) <volume>214</volume>:<fpage>60</fpage>&#8211;<lpage>5.e2</lpage>. <pub-id pub-id-type="doi">10.1016/j.jpeds.2019.07.032</pub-id><pub-id pub-id-type="pmid">31474426</pub-id><pub-id pub-id-type="pmcid">PMC10564583</pub-id></mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yen</surname><given-names>E</given-names></name><name name-style="western"><surname>Madan</surname><given-names>N</given-names></name><name name-style="western"><surname>Tarui</surname><given-names>T</given-names></name><name name-style="western"><surname>Kaneko-Tarui</surname><given-names>T</given-names></name><name name-style="western"><surname>Breeze</surname><given-names>JL</given-names></name><name name-style="western"><surname>Davis</surname><given-names>JM</given-names></name><etal/></person-group><article-title>Sex-specific inflammatory and white matter effects of prenatal opioid exposure: a pilot study</article-title>. <source>Pediatr Res</source>. (<year>2023</year>) <volume>93</volume>(<issue>3</issue>):<fpage>604</fpage>&#8211;<lpage>11</lpage>. <pub-id pub-id-type="doi">10.1038/s41390-022-02357-5</pub-id><pub-id pub-id-type="pmid">36280708</pub-id><pub-id pub-id-type="pmcid">PMC9998341</pub-id></mixed-citation></ref><ref id="B33"><label>33.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Grecco</surname><given-names>GG</given-names></name><name name-style="western"><surname>Huang</surname><given-names>JY</given-names></name><name name-style="western"><surname>Mu&#241;oz</surname><given-names>B</given-names></name><name name-style="western"><surname>Doud</surname><given-names>EH</given-names></name><name name-style="western"><surname>Hines</surname><given-names>CD</given-names></name><name name-style="western"><surname>Gao</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Sex-dependent synaptic remodeling of the somatosensory Cortex in mice with prenatal methadone exposure</article-title>. <source>Adv Drug Alcohol Res</source>. (<year>2022</year>) <volume>2</volume>:<fpage>1</fpage>&#8211;<lpage>22</lpage>. <pub-id pub-id-type="doi">10.3389/adar.2022.10400</pub-id><pub-id pub-id-type="pmcid">PMC10569410</pub-id><pub-id pub-id-type="pmid">37829495</pub-id></mixed-citation></ref><ref id="B34"><label>34.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Grecco</surname><given-names>GG</given-names></name><name name-style="western"><surname>Mork</surname><given-names>BE</given-names></name><name name-style="western"><surname>Huang</surname><given-names>JY</given-names></name><name name-style="western"><surname>Metzger</surname><given-names>CE</given-names></name><name name-style="western"><surname>Haggerty</surname><given-names>DL</given-names></name><name name-style="western"><surname>Reeves</surname><given-names>KC</given-names></name><etal/></person-group><article-title>Prenatal methadone exposure disrupts behavioral development and alters motor neuron intrinsic properties and local circuitry</article-title>. <source>eLife</source>. (<year>2021</year>) <volume>10</volume>:<fpage>1</fpage>&#8211;<lpage>29</lpage>. <pub-id pub-id-type="doi">10.7554/eLife.66230</pub-id><pub-id pub-id-type="pmcid">PMC7993998</pub-id><pub-id pub-id-type="pmid">33724184</pub-id></mixed-citation></ref><ref id="B35"><label>35.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Antoine</surname><given-names>D</given-names></name><name name-style="western"><surname>Singh</surname><given-names>PK</given-names></name><name name-style="western"><surname>Tao</surname><given-names>J</given-names></name><name name-style="western"><surname>Roy</surname><given-names>S</given-names></name></person-group>. <article-title>Neonatal morphine results in long-lasting alterations to the gut microbiome in adolescence and adulthood in a murine model</article-title>. <source>Pharmaceutics</source>. (<year>2022</year>) <volume>14</volume>(<issue>9</issue>):<fpage>1879</fpage>. <pub-id pub-id-type="doi">10.3390/pharmaceutics14091879</pub-id><pub-id pub-id-type="pmid">36145627</pub-id><pub-id pub-id-type="pmcid">PMC9503694</pub-id></mixed-citation></ref><ref id="B36"><label>36.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Abu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Tao</surname><given-names>J</given-names></name><name name-style="western"><surname>Dutta</surname><given-names>R</given-names></name><name name-style="western"><surname>Yan</surname><given-names>Y</given-names></name><name name-style="western"><surname>Vitari</surname><given-names>N</given-names></name><name name-style="western"><surname>Kolli</surname><given-names>U</given-names></name><etal/></person-group><article-title>Brief hydromorphone exposure during pregnancy sufficient to induce maternal and neonatal microbial dysbiosis</article-title>. <source>J Neuroimmune Pharmacol</source>. (<year>2022</year>) <volume>17</volume>(<issue>1&#8211;2</issue>):<fpage>367</fpage>&#8211;<lpage>75</lpage>. <pub-id pub-id-type="doi">10.1007/s11481-021-10019-2</pub-id><pub-id pub-id-type="pmid">34562195</pub-id><pub-id pub-id-type="pmcid">PMC10117152</pub-id></mixed-citation></ref><ref id="B37"><label>37.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jalodia</surname><given-names>R</given-names></name><name name-style="western"><surname>Abu</surname><given-names>YF</given-names></name><name name-style="western"><surname>Oppenheimer</surname><given-names>MR</given-names></name><name name-style="western"><surname>Herlihy</surname><given-names>B</given-names></name><name name-style="western"><surname>Meng</surname><given-names>J</given-names></name><name name-style="western"><surname>Chupikova</surname><given-names>I</given-names></name><etal/></person-group><article-title>Opioid use, gut dysbiosis, inflammation, and the nervous system</article-title>. <source>J Neuroimmune Pharmacol</source>. (<year>2022</year>) <volume>17</volume>(<issue>1&#8211;2</issue>):<fpage>76</fpage>&#8211;<lpage>93</lpage>. <pub-id pub-id-type="doi">10.1007/s11481-021-10046-z</pub-id><pub-id pub-id-type="pmid">34993905</pub-id><pub-id pub-id-type="pmcid">PMC10276355</pub-id></mixed-citation></ref><ref id="B38"><label>38.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hauser</surname><given-names>KF</given-names></name><name name-style="western"><surname>Knapp</surname><given-names>PE</given-names></name></person-group>. <article-title>Opiate drugs with abuse liability hijack the endogenous opioid system to disrupt neuronal and glial maturation in the central nervous system</article-title>. <source>Front Pediatr</source>. (<year>2018</year>) <volume>5</volume>:<fpage>1</fpage>&#8211;<lpage>23</lpage>. <pub-id pub-id-type="doi">10.3389/fped.2017.00294</pub-id><pub-id pub-id-type="pmcid">PMC5787058</pub-id><pub-id pub-id-type="pmid">29410949</pub-id></mixed-citation></ref><ref id="B39"><label>39.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Velasco</surname><given-names>B</given-names></name><name name-style="western"><surname>Mohamed</surname><given-names>E</given-names></name><name name-style="western"><surname>Sato-Bigbee</surname><given-names>C</given-names></name></person-group>. <article-title>Endogenous and exogenous opioid effects on oligodendrocyte biology and developmental brain myelination</article-title>. <source>Neurotoxicol Teratol</source>. (<year>2021</year>) <volume>86</volume>:<fpage>107002</fpage>. <pub-id pub-id-type="doi">10.1016/j.ntt.2021.107002</pub-id><pub-id pub-id-type="pmid">34126203</pub-id><pub-id pub-id-type="pmcid">PMC8277740</pub-id></mixed-citation></ref><ref id="B40"><label>40.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Merhar</surname><given-names>SL</given-names></name><name name-style="western"><surname>Parikh</surname><given-names>NA</given-names></name><name name-style="western"><surname>Braimah</surname><given-names>A</given-names></name><name name-style="western"><surname>Poindexter</surname><given-names>BB</given-names></name><name name-style="western"><surname>Tkach</surname><given-names>J</given-names></name><name name-style="western"><surname>Kline-Fath</surname><given-names>B</given-names></name></person-group>. <article-title>White matter injury and structural anomalies in infants with prenatal opioid exposue</article-title>. <source>Am J Neuroradiol</source>. (<year>2019</year>) 40:2161&#8211;5. <pub-id pub-id-type="doi">10.3174/ajnr.A6282</pub-id><pub-id pub-id-type="pmid">31624119</pub-id><pub-id pub-id-type="pmcid">PMC6911627</pub-id></mixed-citation></ref><ref id="B41"><label>41.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mohamed</surname><given-names>E</given-names></name><name name-style="western"><surname>Paisley</surname><given-names>CE</given-names></name><name name-style="western"><surname>Meyer</surname><given-names>LC</given-names></name><name name-style="western"><surname>Bigbee</surname><given-names>JW</given-names></name><name name-style="western"><surname>Sato-Bigbee</surname><given-names>C</given-names></name></person-group>. <article-title>Endogenous opioid peptides and brain development: endomorphin-1 and nociceptin play a sex-specific role in the control of oligodendrocyte maturation and brain myelination</article-title>. <source>Glia</source>. (<year>2020</year>) <volume>68</volume>(<issue>7</issue>):<fpage>1513</fpage>&#8211;<lpage>30</lpage>. <pub-id pub-id-type="doi">10.1002/glia.23799</pub-id><pub-id pub-id-type="pmid">32065429</pub-id><pub-id pub-id-type="pmcid">PMC11006003</pub-id></mixed-citation></ref><ref id="B42"><label>42.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Reeves</surname><given-names>KC</given-names></name><name name-style="western"><surname>Shah</surname><given-names>N</given-names></name><name name-style="western"><surname>Mu&#241;oz</surname><given-names>B</given-names></name><name name-style="western"><surname>Atwood</surname><given-names>BK</given-names></name></person-group>. <article-title>Opioid receptor-mediated regulation of neurotransmission in the brain</article-title>. <source>Front Mol Neurosci</source>. (<year>2022</year>) <volume>15</volume>:<fpage>1</fpage>&#8211;<lpage>28</lpage>. <pub-id pub-id-type="doi">10.3389/fnmol.2022.919773</pub-id><pub-id pub-id-type="pmcid">PMC9242007</pub-id><pub-id pub-id-type="pmid">35782382</pub-id></mixed-citation></ref><ref id="B43"><label>43.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hou</surname><given-names>Y</given-names></name><name name-style="western"><surname>Tan</surname><given-names>Y</given-names></name><name name-style="western"><surname>Belcheva</surname><given-names>MM</given-names></name><name name-style="western"><surname>Clark</surname><given-names>AL</given-names></name><name name-style="western"><surname>Zahm</surname><given-names>DS</given-names></name><name name-style="western"><surname>Coscia</surname><given-names>CJ</given-names></name></person-group>. <article-title>Differential effects of gestational buprenorphine, naloxone, and methadone on mesolimbic <italic toggle="yes">&#956;</italic> opioid and ORL1 receptor G protein coupling</article-title>. <source>Dev Brain Res</source>. (<year>2004</year>) <volume>151</volume>(<issue>1&#8211;2</issue>):<fpage>149</fpage>&#8211;<lpage>57</lpage>. <pub-id pub-id-type="doi">10.1016/j.devbrainres.2004.05.002</pub-id><pub-id pub-id-type="pmid">15246701</pub-id></mixed-citation></ref><ref id="B44"><label>44.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Boggess</surname><given-names>T</given-names></name><name name-style="western"><surname>Williamson</surname><given-names>JC</given-names></name><name name-style="western"><surname>Niebergall</surname><given-names>EB</given-names></name><name name-style="western"><surname>Sexton</surname><given-names>H</given-names></name><name name-style="western"><surname>Mazur</surname><given-names>A</given-names></name><name name-style="western"><surname>Egleton</surname><given-names>RD</given-names></name><etal/></person-group><article-title>Alterations in excitatory and inhibitory synaptic development within the mesolimbic dopamine pathway in a mouse model of prenatal drug exposure</article-title>. <source>Front Pediatr</source>. (<year>2021</year>) <volume>9</volume>:<fpage>1</fpage>&#8211;<lpage>14</lpage>. <pub-id pub-id-type="doi">10.3389/fped.2021.794544</pub-id><pub-id pub-id-type="pmcid">PMC8710665</pub-id><pub-id pub-id-type="pmid">34966707</pub-id></mixed-citation></ref><ref id="B45"><label>45.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>McCarthy</surname><given-names>MM</given-names></name><name name-style="western"><surname>Nugent</surname><given-names>BM</given-names></name><name name-style="western"><surname>Lenz</surname><given-names>KM</given-names></name></person-group>. <article-title>Neuroimmunology and neuroepigenetics in the establishment of sex differences in the brain</article-title>. <source>Nat Rev Neurosci</source>. (<year>2017</year>) <volume>18</volume>(<issue>8</issue>):<fpage>471</fpage>&#8211;<lpage>84</lpage>. <pub-id pub-id-type="doi">10.1038/nrn.2017.61</pub-id><pub-id pub-id-type="pmid">28638119</pub-id><pub-id pub-id-type="pmcid">PMC5771241</pub-id></mixed-citation></ref><ref id="B46"><label>46.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Arambula</surname><given-names>SE</given-names></name><name name-style="western"><surname>McCarthy</surname><given-names>MM</given-names></name></person-group>. <article-title>Neuroendocrine-immune crosstalk shapes sex-specific brain development</article-title>. <source>Endocrinology</source>. (<year>2020</year>) <volume>161</volume>(<issue>6</issue>):<fpage>1</fpage>&#8211;<lpage>13</lpage>. <pub-id pub-id-type="doi">10.1210/endocr/bqaa055</pub-id><pub-id pub-id-type="pmcid">PMC7217281</pub-id><pub-id pub-id-type="pmid">32270188</pub-id></mixed-citation></ref><ref id="B47"><label>47.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sinchak</surname><given-names>K</given-names></name><name name-style="western"><surname>Micevych</surname><given-names>PE</given-names></name></person-group>. <article-title>Progesterone blockade of estrogen activation of &#956;-opioid receptors regulates reproductive behavior</article-title>. <source>J Neurosci</source>. (<year>2001</year>) <volume>21</volume>(<issue>15</issue>):<fpage>5723</fpage>&#8211;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.21-15-05723.2001</pub-id><pub-id pub-id-type="pmid">11466444</pub-id><pub-id pub-id-type="pmcid">PMC6762652</pub-id></mixed-citation></ref><ref id="B48"><label>48.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Micevych</surname><given-names>PE</given-names></name><name name-style="western"><surname>Rissman</surname><given-names>EF</given-names></name><name name-style="western"><surname>Gustafsson</surname><given-names>J</given-names></name><name name-style="western"><surname>Sinchak</surname><given-names>K</given-names></name></person-group>. <article-title>Estrogen receptor-<italic toggle="yes">&#945;</italic> is required for estrogen-induced &#956;-opioid receptor internalization</article-title>. <source>J Neurosci Res</source>. (<year>2003</year>) <volume>71</volume>(<issue>6</issue>):<fpage>802</fpage>&#8211;<lpage>10</lpage>. <pub-id pub-id-type="doi">10.1002/jnr.10526</pub-id><pub-id pub-id-type="pmid">12605406</pub-id></mixed-citation></ref><ref id="B49"><label>49.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sato</surname><given-names>SM</given-names></name><name name-style="western"><surname>Schulz</surname><given-names>KM</given-names></name><name name-style="western"><surname>Sisk</surname><given-names>CL</given-names></name><name name-style="western"><surname>Wood</surname><given-names>RI</given-names></name></person-group>. <article-title>Adolescents and androgens, receptors and rewards</article-title>. <source>Horm Behav</source>. (<year>2008</year>) <volume>53</volume>(<issue>5</issue>):<fpage>647</fpage>&#8211;<lpage>58</lpage>. <pub-id pub-id-type="doi">10.1016/j.yhbeh.2008.01.010</pub-id><pub-id pub-id-type="pmid">18343381</pub-id><pub-id pub-id-type="pmcid">PMC2435368</pub-id></mixed-citation></ref><ref id="B50"><label>50.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sharp</surname><given-names>JL</given-names></name><name name-style="western"><surname>Pearson</surname><given-names>T</given-names></name><name name-style="western"><surname>Smith</surname><given-names>MA</given-names></name></person-group>. <article-title>Sex differences in opioid receptor mediated effects: role of androgens</article-title>. <source>Neurosci Biobehav Rev</source>. (<year>2022</year>) <volume>134</volume>:<fpage>104522</fpage>. <pub-id pub-id-type="doi">10.1016/j.neubiorev.2022.104522</pub-id><pub-id pub-id-type="pmid">34995646</pub-id><pub-id pub-id-type="pmcid">PMC8872632</pub-id></mixed-citation></ref><ref id="B51"><label>51.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bernal</surname><given-names>SA</given-names></name><name name-style="western"><surname>Morgan</surname><given-names>MM</given-names></name><name name-style="western"><surname>Craft</surname><given-names>RM</given-names></name></person-group>. <article-title>PAG Mu opioid receptor activation underlies sex differences in morphine antinociception</article-title>. <source>Behav Brain Res</source>. (<year>2007</year>) <volume>177</volume>(<issue>1</issue>):<fpage>126</fpage>&#8211;<lpage>33</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbr.2006.10.028</pub-id><pub-id pub-id-type="pmid">17118467</pub-id><pub-id pub-id-type="pmcid">PMC1868665</pub-id></mixed-citation></ref><ref id="B52"><label>52.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pluchino</surname><given-names>N</given-names></name><name name-style="western"><surname>Ninni</surname><given-names>F</given-names></name><name name-style="western"><surname>Casarosa</surname><given-names>E</given-names></name><name name-style="western"><surname>Giannini</surname><given-names>A</given-names></name><name name-style="western"><surname>Merlini</surname><given-names>S</given-names></name><name name-style="western"><surname>Cubeddu</surname><given-names>A</given-names></name><etal/></person-group><article-title>Sex differences in brain and plasma beta-endorphin content following testosterone, dihydrotestosterone and estradiol administration to gonadectomized rats</article-title>. <source>Neuroendocrinology</source>. (<year>2009</year>) <volume>89</volume>(<issue>4</issue>):<fpage>411</fpage>&#8211;<lpage>23</lpage>. <pub-id pub-id-type="doi">10.1159/000209506</pub-id><pub-id pub-id-type="pmid">19295188</pub-id></mixed-citation></ref><ref id="B53"><label>53.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bradshaw</surname><given-names>H</given-names></name><name name-style="western"><surname>Miller</surname><given-names>J</given-names></name><name name-style="western"><surname>Ling</surname><given-names>Q</given-names></name><name name-style="western"><surname>Malsnee</surname><given-names>K</given-names></name><name name-style="western"><surname>Ruda</surname><given-names>MA</given-names></name></person-group>. <article-title>Sex differences and phases of the estrous cycle alter the response of spinal cord dynorphin neurons to peripheral inflammation and hyperalgesia</article-title>. <source>Pain</source>. (<year>2000</year>) <volume>85</volume>(<issue>1&#8211;2</issue>):<fpage>93</fpage>&#8211;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/S0304-3959(99)00253-5</pub-id><pub-id pub-id-type="pmid">10692607</pub-id></mixed-citation></ref><ref id="B54"><label>54.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sithisarn</surname><given-names>T</given-names></name><name name-style="western"><surname>Bada</surname><given-names>HS</given-names></name><name name-style="western"><surname>Dai</surname><given-names>H</given-names></name><name name-style="western"><surname>Reinhardt</surname><given-names>CR</given-names></name><name name-style="western"><surname>Randall</surname><given-names>DC</given-names></name><name name-style="western"><surname>Legan</surname><given-names>SJ</given-names></name></person-group>. <article-title>Effects of perinatal oxycodone exposure on the response to CRH in late adolescent rats</article-title>. <source>Neurotoxicol Teratol</source>. (<year>2008</year>) <volume>30</volume>(<issue>2</issue>):<fpage>118</fpage>&#8211;<lpage>24</lpage>. <pub-id pub-id-type="doi">10.1016/j.ntt.2007.12.010</pub-id><pub-id pub-id-type="pmid">18255259</pub-id></mixed-citation></ref><ref id="B55"><label>55.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Grecco</surname><given-names>GG</given-names></name><name name-style="western"><surname>Gao</surname><given-names>Y</given-names></name><name name-style="western"><surname>Gao</surname><given-names>H</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Atwood</surname><given-names>BK</given-names></name></person-group>. <article-title>Prenatal opioid administration induces shared alterations to the maternal and offspring gut microbiome: a preliminary analysis</article-title>. <source>Drug Alcohol Depend</source>. (<year>2021</year>) <volume>227</volume>:<fpage>108914</fpage>. <pub-id pub-id-type="doi">10.1016/j.drugalcdep.2021.108914</pub-id><pub-id pub-id-type="pmid">34364194</pub-id><pub-id pub-id-type="pmcid">PMC8464518</pub-id></mixed-citation></ref><ref id="B56"><label>56.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Grecco</surname><given-names>GG</given-names></name><name name-style="western"><surname>Haggerty</surname><given-names>DL</given-names></name><name name-style="western"><surname>Reeves</surname><given-names>KC</given-names></name><name name-style="western"><surname>Gao</surname><given-names>Y</given-names></name><name name-style="western"><surname>Maulucci</surname><given-names>D</given-names></name><name name-style="western"><surname>Atwood</surname><given-names>BK</given-names></name></person-group>. <article-title>Prenatal opioid exposure reprograms the behavioural response to future alcohol reward</article-title>. <source>Addict Biol</source>. (<year>2022</year>) <volume>27</volume>(<issue>2</issue>):<fpage>1</fpage>&#8211;<lpage>21</lpage>. <pub-id pub-id-type="doi">10.1111/adb.13136</pub-id><pub-id pub-id-type="pmcid">PMC8896285</pub-id><pub-id pub-id-type="pmid">35229956</pub-id></mixed-citation></ref><ref id="B57"><label>57.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vathy</surname><given-names>I</given-names></name><name name-style="western"><surname>&#352;lamberov&#225;</surname><given-names>R</given-names></name><name name-style="western"><surname>Riman&#243;czy</surname><given-names>&#193;</given-names></name><name name-style="western"><surname>Riley</surname><given-names>MA</given-names></name><name name-style="western"><surname>Bar</surname><given-names>N</given-names></name></person-group>. <article-title>Autoradiographic evidence that prenatal morphine exposure sex-dependently alters &#956;-opioid receptor densities in brain regions that are involved in the control of drug abuse and other motivated behaviors</article-title>. <source>Prog Neuropsychopharmacol Biol Psychiatry</source>. (<year>2003</year>) <volume>27</volume>(<issue>3</issue>):<fpage>381</fpage>&#8211;<lpage>93</lpage>. <pub-id pub-id-type="doi">10.1016/S0278-5846(02)00355-X</pub-id><pub-id pub-id-type="pmid">12691773</pub-id></mixed-citation></ref><ref id="B58"><label>58.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Smith</surname><given-names>BL</given-names></name><name name-style="western"><surname>Guzman</surname><given-names>TA</given-names></name><name name-style="western"><surname>Brendle</surname><given-names>AH</given-names></name><name name-style="western"><surname>Laaker</surname><given-names>CJ</given-names></name><name name-style="western"><surname>Ford</surname><given-names>A</given-names></name><name name-style="western"><surname>Hiltz</surname><given-names>AR</given-names></name><etal/></person-group><article-title>Perinatal morphine exposure leads to sex-dependent executive function deficits and microglial changes in mice</article-title>. <source>eNeuro</source>. (<year>2022</year>) <volume>9</volume>(<issue>5</issue>):<fpage>ENEURO.0238-22.2022</fpage>. <pub-id pub-id-type="doi">10.1523/ENEURO.0238-22.2022</pub-id><pub-id pub-id-type="pmid">36216505</pub-id><pub-id pub-id-type="pmcid">PMC9581576</pub-id></mixed-citation></ref><ref id="B59"><label>59.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Volkow</surname><given-names>ND</given-names></name><name name-style="western"><surname>Jones</surname><given-names>EB</given-names></name><name name-style="western"><surname>Einstein</surname><given-names>EB</given-names></name><name name-style="western"><surname>Wargo</surname><given-names>EM</given-names></name></person-group>. <article-title>Prevention and treatment of opioid misuse and addiction</article-title>. <source>JAMA Psychiatry</source>. (<year>2019</year>) <volume>76</volume>(<issue>2</issue>):<fpage>208</fpage>. <pub-id pub-id-type="doi">10.1001/jamapsychiatry.2018.3126</pub-id><pub-id pub-id-type="pmid">30516809</pub-id></mixed-citation></ref><ref id="B60"><label>60.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Blanco</surname><given-names>C</given-names></name><name name-style="western"><surname>Volkow</surname><given-names>ND</given-names></name></person-group>. <article-title>Management of opioid use disorder in the USA: present status and future directions</article-title>. <source>Lancet</source>. (<year>2019</year>) <volume>393</volume>(<issue>10182</issue>):<fpage>1760</fpage>&#8211;<lpage>72</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(18)33078-2</pub-id><pub-id pub-id-type="pmid">30878228</pub-id></mixed-citation></ref><ref id="B61"><label>61.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Han</surname><given-names>B</given-names></name><name name-style="western"><surname>Compton</surname><given-names>WM</given-names></name><name name-style="western"><surname>Einstein</surname><given-names>EB</given-names></name><name name-style="western"><surname>Elder</surname><given-names>E</given-names></name><name name-style="western"><surname>Volkow</surname><given-names>ND</given-names></name></person-group>. <article-title>Pregnancy and postpartum drug overdose deaths in the US before and during the COVID-19 pandemic</article-title>. <source>JAMA Psychiatry</source>. (<year>2023</year>) 81(3):270&#8211;83. <pub-id pub-id-type="doi">10.1001/jamapsychiatry.2023.4523</pub-id><pub-id pub-id-type="pmcid">PMC10918496</pub-id><pub-id pub-id-type="pmid">37991773</pub-id></mixed-citation></ref><ref id="B62"><label>62.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Huhn</surname><given-names>AS</given-names></name><name name-style="western"><surname>Berry</surname><given-names>MS</given-names></name><name name-style="western"><surname>Dunn</surname><given-names>KE</given-names></name></person-group>. <article-title>Review: sex-based differences in treatment outcomes for persons with opioid use disorder</article-title>. <source>Am J Addict</source>. (<year>2019</year>) <volume>28</volume>(<issue>4</issue>):<fpage>246</fpage>&#8211;<lpage>61</lpage>. <pub-id pub-id-type="doi">10.1111/ajad.12921</pub-id><pub-id pub-id-type="pmid">31131505</pub-id><pub-id pub-id-type="pmcid">PMC6591072</pub-id></mixed-citation></ref><ref id="B63"><label>63.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Huhn</surname><given-names>AS</given-names></name><name name-style="western"><surname>Berry</surname><given-names>MS</given-names></name><name name-style="western"><surname>Dunn</surname><given-names>KE</given-names></name></person-group>. <article-title>Systematic review of sex-based differences in opioid-based effects</article-title>. <source>Int Rev Psychiatry</source>. (<year>2018</year>) <volume>30</volume>(<issue>5</issue>):<fpage>107</fpage>&#8211;<lpage>16</lpage>. <pub-id pub-id-type="doi">10.1080/09540261.2018.1514295</pub-id><pub-id pub-id-type="pmid">30522374</pub-id><pub-id pub-id-type="pmcid">PMC6551331</pub-id></mixed-citation></ref><ref id="B64"><label>64.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Davis</surname><given-names>JP</given-names></name><name name-style="western"><surname>Eddie</surname><given-names>D</given-names></name><name name-style="western"><surname>Prindle</surname><given-names>J</given-names></name><name name-style="western"><surname>Dworkin</surname><given-names>ER</given-names></name><name name-style="western"><surname>Christie</surname><given-names>NC</given-names></name><name name-style="western"><surname>Saba</surname><given-names>S</given-names></name><etal/></person-group><article-title>Sex differences in factors predicting post-treatment opioid use</article-title>. <source>Addiction</source>. (<year>2021</year>) <volume>116</volume>(<issue>8</issue>):<fpage>2116</fpage>&#8211;<lpage>26</lpage>. <pub-id pub-id-type="doi">10.1111/add.15396</pub-id><pub-id pub-id-type="pmid">33405314</pub-id><pub-id pub-id-type="pmcid">PMC8254742</pub-id></mixed-citation></ref><ref id="B65"><label>65.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Minozzi</surname><given-names>S</given-names></name><name name-style="western"><surname>Amato</surname><given-names>L</given-names></name><name name-style="western"><surname>Jahanfar</surname><given-names>S</given-names></name><name name-style="western"><surname>Bellisario</surname><given-names>C</given-names></name><name name-style="western"><surname>Ferri</surname><given-names>M</given-names></name><name name-style="western"><surname>Davoli</surname><given-names>M</given-names></name></person-group>. <article-title>Maintenance agonist treatments for opiate-dependent pregnant women</article-title>. <source>Cochrane Database Syst Rev</source>. (<year>2020</year>) <volume>2020</volume>(<issue>11</issue>):<fpage>1</fpage>&#8211;<lpage>20</lpage>. <pub-id pub-id-type="doi">10.1002/14651858.CD012557.pub2</pub-id><pub-id pub-id-type="pmcid">PMC8094273</pub-id><pub-id pub-id-type="pmid">33165953</pub-id></mixed-citation></ref><ref id="B66"><label>66.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jansson</surname><given-names>LM</given-names></name><name name-style="western"><surname>Velez</surname><given-names>ML</given-names></name><name name-style="western"><surname>McConnell</surname><given-names>K</given-names></name><name name-style="western"><surname>Spencer</surname><given-names>N</given-names></name><name name-style="western"><surname>Tuten</surname><given-names>M</given-names></name><name name-style="western"><surname>Jones</surname><given-names>H</given-names></name><etal/></person-group><article-title>Maternal buprenorphine treatment and infant outcome</article-title>. <source>Drug Alcohol Depend</source>. (<year>2017</year>) <volume>180</volume>:<fpage>56</fpage>&#8211;<lpage>61</lpage>. <pub-id pub-id-type="doi">10.1016/j.drugalcdep.2017.08.001</pub-id><pub-id pub-id-type="pmid">28869859</pub-id><pub-id pub-id-type="pmcid">PMC5788458</pub-id></mixed-citation></ref><ref id="B67"><label>67.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Favara</surname><given-names>MT</given-names></name><name name-style="western"><surname>Carola</surname><given-names>D</given-names></name><name name-style="western"><surname>Jensen</surname><given-names>E</given-names></name><name name-style="western"><surname>Cook</surname><given-names>A</given-names></name><name name-style="western"><surname>Genen</surname><given-names>L</given-names></name><name name-style="western"><surname>Dysart</surname><given-names>K</given-names></name><etal/></person-group><article-title>Maternal breast milk feeding and length of treatment in infants with neonatal abstinence syndrome</article-title>. <source>J Perinatol</source>. (<year>2019</year>) <volume>39</volume>(<issue>6</issue>):<fpage>876</fpage>&#8211;<lpage>82</lpage>. <pub-id pub-id-type="doi">10.1038/s41372-019-0374-1</pub-id><pub-id pub-id-type="pmid">30988400</pub-id></mixed-citation></ref><ref id="B68"><label>68.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bogen</surname><given-names>DL</given-names></name><name name-style="western"><surname>Whalen</surname><given-names>BL</given-names></name><name name-style="western"><surname>Kair</surname><given-names>LR</given-names></name><name name-style="western"><surname>Vining</surname><given-names>M</given-names></name><name name-style="western"><surname>King</surname><given-names>BA</given-names></name></person-group>. <article-title>Wide variation found in care of opioid-exposed newborns</article-title>. <source>Acad Pediatr</source>. (<year>2017</year>) <volume>17</volume>(<issue>4</issue>):<fpage>374</fpage>&#8211;<lpage>80</lpage>. <pub-id pub-id-type="doi">10.1016/j.acap.2016.10.003</pub-id><pub-id pub-id-type="pmid">27889436</pub-id><pub-id pub-id-type="pmcid">PMC5420467</pub-id></mixed-citation></ref><ref id="B69"><label>69.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Krans</surname><given-names>EE</given-names></name><name name-style="western"><surname>Kim</surname><given-names>JY</given-names></name><name name-style="western"><surname>Chen</surname><given-names>Q</given-names></name><name name-style="western"><surname>Rothenberger</surname><given-names>SD</given-names></name><name name-style="western"><surname>James</surname><given-names>AE</given-names></name><name name-style="western"><surname>Kelley</surname><given-names>D</given-names></name><etal/></person-group><article-title>Outcomes associated with the use of medications for opioid use disorder during pregnancy</article-title>. <source>Addiction</source>. (<year>2021</year>) <volume>116</volume>(<issue>12</issue>):<fpage>3504</fpage>&#8211;<lpage>14</lpage>. <pub-id pub-id-type="doi">10.1111/add.15582</pub-id><pub-id pub-id-type="pmid">34033170</pub-id><pub-id pub-id-type="pmcid">PMC8578145</pub-id></mixed-citation></ref><ref id="B70"><label>70.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yen</surname><given-names>E</given-names></name><name name-style="western"><surname>Gaddis</surname><given-names>N</given-names></name><name name-style="western"><surname>Jantzie</surname><given-names>L</given-names></name><name name-style="western"><surname>Davis</surname><given-names>JM</given-names></name></person-group>. <article-title>A review of the genomics of neonatal abstinence syndrome</article-title>. <source>Front Genet</source>. (<year>2023</year>) <volume>14</volume>:<fpage>1</fpage>&#8211;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.3389/fgene.2023.1140400</pub-id><pub-id pub-id-type="pmcid">PMC9950123</pub-id><pub-id pub-id-type="pmid">36845389</pub-id></mixed-citation></ref><ref id="B71"><label>71.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>O&#8217;Connor</surname><given-names>AB</given-names></name><name name-style="western"><surname>O&#8217;Brien</surname><given-names>L</given-names></name><name name-style="western"><surname>Alto</surname><given-names>WA</given-names></name></person-group>. <article-title>Are there gender related differences in neonatal abstinence syndrome following exposure to buprenorphine during pregnancy?</article-title><source>JPME</source>. (<year>2013</year>) <volume>41</volume>(<issue>5</issue>):<fpage>621</fpage>&#8211;<lpage>3</lpage>. <pub-id pub-id-type="doi">10.1515/jpm-2012-0288</pub-id><pub-id pub-id-type="pmid">23612625</pub-id></mixed-citation></ref><ref id="B72"><label>72.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Patrick</surname><given-names>SW</given-names></name><name name-style="western"><surname>Slaughter</surname><given-names>JC</given-names></name><name name-style="western"><surname>Harrell</surname><given-names>FE</given-names></name><name name-style="western"><surname>Martin</surname><given-names>PR</given-names></name><name name-style="western"><surname>Hartmann</surname><given-names>K</given-names></name><name name-style="western"><surname>Dudley</surname><given-names>J</given-names></name><etal/></person-group><article-title>Development and validation of a model to predict neonatal abstinence syndrome</article-title>. <source>J Pediatr</source>. (<year>2021</year>) <volume>229</volume>:<fpage>154</fpage>&#8211;<lpage>60.e6</lpage>. <pub-id pub-id-type="doi">10.1016/j.jpeds.2020.10.030</pub-id><pub-id pub-id-type="pmid">33080277</pub-id><pub-id pub-id-type="pmcid">PMC7855864</pub-id></mixed-citation></ref><ref id="B73"><label>73.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Conradt</surname><given-names>E</given-names></name><name name-style="western"><surname>Flannery</surname><given-names>T</given-names></name><name name-style="western"><surname>Aschner</surname><given-names>JL</given-names></name><name name-style="western"><surname>Annett</surname><given-names>RD</given-names></name><name name-style="western"><surname>Croen</surname><given-names>LA</given-names></name><name name-style="western"><surname>Duarte</surname><given-names>CS</given-names></name><etal/></person-group><article-title>Prenatal opioid exposure: neurodevelopmental consequences and future research priorities</article-title>. <source>Pediatrics</source>. (<year>2019</year>) <volume>144</volume>(<issue>3</issue>):<fpage>1</fpage>&#8211;<lpage>25</lpage>. <pub-id pub-id-type="doi">10.1542/peds.2019-0128</pub-id><pub-id pub-id-type="pmcid">PMC6759228</pub-id><pub-id pub-id-type="pmid">31462446</pub-id></mixed-citation></ref><ref id="B74"><label>74.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nygaard</surname><given-names>E</given-names></name><name name-style="western"><surname>Moe</surname><given-names>V</given-names></name><name name-style="western"><surname>Slinning</surname><given-names>K</given-names></name><name name-style="western"><surname>Walhovd</surname><given-names>KB</given-names></name></person-group>. <article-title>Longitudinal cognitive development of children born to mothers with opioid and polysubstance use</article-title>. <source>Pediatr Res</source>. (<year>2015</year>) <volume>78</volume>(<issue>3</issue>):<fpage>330</fpage>&#8211;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1038/pr.2015.95</pub-id><pub-id pub-id-type="pmid">25978800</pub-id><pub-id pub-id-type="pmcid">PMC4539602</pub-id></mixed-citation></ref><ref id="B75"><label>75.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mactier</surname><given-names>H</given-names></name><name name-style="western"><surname>McLaughlin</surname><given-names>P</given-names></name><name name-style="western"><surname>Gillis</surname><given-names>C</given-names></name><name name-style="western"><surname>Osselton</surname><given-names>M</given-names></name></person-group>. <article-title>Variations in infant CYP2B6 genotype associated with the need for pharmacological treatment for neonatal abstinence syndrome in infants of methadone-maintained opioid-dependent mothers</article-title>. <source>Am J Perinatol</source>. (<year>2017</year>) <volume>34</volume>(<issue>09</issue>):<fpage>918</fpage>&#8211;<lpage>21</lpage>. <pub-id pub-id-type="doi">10.1055/s-0037-1600917</pub-id><pub-id pub-id-type="pmid">28320034</pub-id></mixed-citation></ref><ref id="B76"><label>76.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>McLaughlin</surname><given-names>P</given-names></name><name name-style="western"><surname>Mactier</surname><given-names>H</given-names></name><name name-style="western"><surname>Gillis</surname><given-names>C</given-names></name><name name-style="western"><surname>Hickish</surname><given-names>T</given-names></name><name name-style="western"><surname>Parker</surname><given-names>A</given-names></name><name name-style="western"><surname>Liang</surname><given-names>WJ</given-names></name><etal/></person-group><article-title>Increased DNA methylation of ABCB1, CYP2D6, and OPRM1 genes in newborn infants of methadone-maintained opioid-dependent mothers</article-title>. <source>J Pediatr</source>. (<year>2017</year>) <volume>190</volume>:<fpage>180</fpage>&#8211;<lpage>4.e1</lpage>. <pub-id pub-id-type="doi">10.1016/j.jpeds.2017.07.026</pub-id><pub-id pub-id-type="pmid">28867064</pub-id></mixed-citation></ref><ref id="B77"><label>77.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wachman</surname><given-names>EM</given-names></name><name name-style="western"><surname>Hayes</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Shrestha</surname><given-names>H</given-names></name><name name-style="western"><surname>Nikita</surname><given-names>FNU</given-names></name><name name-style="western"><surname>Nolin</surname><given-names>A</given-names></name><name name-style="western"><surname>Hoyo</surname><given-names>L</given-names></name><etal/></person-group><article-title>Epigenetic variation in <italic toggle="yes">OPRM1</italic> gene in opioid-exposed mother-infant dyads</article-title>. <source>Genes Brain Behav</source>. (<year>2018</year>) <volume>17</volume>(<issue>7</issue>):<fpage>1</fpage>&#8211;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1111/gbb.12476</pub-id><pub-id pub-id-type="pmid">29575474</pub-id></mixed-citation></ref><ref id="B78"><label>78.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wachman</surname><given-names>EM</given-names></name><name name-style="western"><surname>Hayes</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Sherva</surname><given-names>R</given-names></name><name name-style="western"><surname>Brown</surname><given-names>MS</given-names></name><name name-style="western"><surname>Davis</surname><given-names>JM</given-names></name><name name-style="western"><surname>Farrer</surname><given-names>LA</given-names></name><etal/></person-group><article-title>Variations in opioid receptor genes in neonatal abstinence syndrome</article-title>. <source>Drug Alcohol Depend</source>. (<year>2015</year>) <volume>155</volume>:<fpage>253</fpage>&#8211;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/j.drugalcdep.2015.07.001</pub-id><pub-id pub-id-type="pmid">26233486</pub-id><pub-id pub-id-type="pmcid">PMC4581974</pub-id></mixed-citation></ref><ref id="B79"><label>79.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Oei</surname><given-names>JL</given-names></name><name name-style="western"><surname>Xu</surname><given-names>HX</given-names></name><name name-style="western"><surname>Abdel-Latif</surname><given-names>ME</given-names></name><name name-style="western"><surname>Vunnam</surname><given-names>K</given-names></name><name name-style="western"><surname>Al-Amry</surname><given-names>A</given-names></name><name name-style="western"><surname>Clews</surname><given-names>S</given-names></name><etal/></person-group><article-title>Dopamine D2 receptor gene polymorphisms in newborn infants of drug-using women</article-title>. <source>Arch Dis Child Fetal Neonatal Ed</source>. (<year>2012</year>) <volume>97</volume>(<issue>3</issue>):<fpage>F193</fpage>&#8211;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1136/archdischild-2011-300235</pub-id><pub-id pub-id-type="pmid">21948329</pub-id></mixed-citation></ref><ref id="B80"><label>80.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bibi</surname><given-names>S</given-names></name><name name-style="western"><surname>Gaddis</surname><given-names>N</given-names></name><name name-style="western"><surname>Johnson</surname><given-names>EO</given-names></name><name name-style="western"><surname>Lester</surname><given-names>BM</given-names></name><name name-style="western"><surname>Kraft</surname><given-names>W</given-names></name><name name-style="western"><surname>Singh</surname><given-names>R</given-names></name><etal/></person-group><article-title>Polygenic risk scores and the need for pharmacotherapy in neonatal abstinence syndrome</article-title>. <source>Pediatr Res</source>. (<year>2023</year>) <volume>93</volume>(<issue>5</issue>):<fpage>1368</fpage>&#8211;<lpage>74</lpage>. <pub-id pub-id-type="doi">10.1038/s41390-022-02243-0</pub-id><pub-id pub-id-type="pmid">35974158</pub-id><pub-id pub-id-type="pmcid">PMC9931940</pub-id></mixed-citation></ref><ref id="B81"><label>81.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Camerota</surname><given-names>M</given-names></name><name name-style="western"><surname>Davis</surname><given-names>JM</given-names></name><name name-style="western"><surname>Dansereau</surname><given-names>LM</given-names></name><name name-style="western"><surname>Oliveira</surname><given-names>EL</given-names></name><name name-style="western"><surname>Padbury</surname><given-names>JF</given-names></name><name name-style="western"><surname>Lester</surname><given-names>BM</given-names></name></person-group>. <article-title>Effects of pharmacologic treatment for neonatal abstinence syndrome on DNA methylation and neurobehavior: a prospective cohort study</article-title>. <source>J Pediatr</source>. (<year>2022</year>) <volume>243</volume>:<fpage>21</fpage>&#8211;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1016/j.jpeds.2021.12.057</pub-id><pub-id pub-id-type="pmid">34971656</pub-id><pub-id pub-id-type="pmcid">PMC8960328</pub-id></mixed-citation></ref><ref id="B82"><label>82.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Terasaki</surname><given-names>LS</given-names></name><name name-style="western"><surname>Gomez</surname><given-names>J</given-names></name><name name-style="western"><surname>Schwarz</surname><given-names>JM</given-names></name></person-group>. <article-title>An examination of sex differences in the effects of early-life opiate and alcohol exposure</article-title>. <source>Philos Trans R Soc, B</source>. (<year>2016</year>) <volume>371</volume>(<issue>1688</issue>):<fpage>20150123</fpage>. <pub-id pub-id-type="doi">10.1098/rstb.2015.0123</pub-id><pub-id pub-id-type="pmcid">PMC4785906</pub-id><pub-id pub-id-type="pmid">26833841</pub-id></mixed-citation></ref><ref id="B83"><label>83.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>DiPietro</surname><given-names>JA</given-names></name><name name-style="western"><surname>Costigan</surname><given-names>KA</given-names></name><name name-style="western"><surname>Voegtline</surname><given-names>KM</given-names></name></person-group>. <article-title>Studies in fetal behavior: revisited, renewed, and reimagined</article-title>. <source>Monogr Soc Res Child Dev</source>. (<year>2015</year>) <volume>80</volume>(<issue>3</issue>):<fpage>vii</fpage>. <pub-id pub-id-type="doi">10.1111/mono.12170</pub-id><pub-id pub-id-type="pmid">26303396</pub-id><pub-id pub-id-type="pmcid">PMC4835043</pub-id></mixed-citation></ref><ref id="B84"><label>84.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Merhar</surname><given-names>SL</given-names></name><name name-style="western"><surname>Kline</surname><given-names>JE</given-names></name><name name-style="western"><surname>Braimah</surname><given-names>A</given-names></name><name name-style="western"><surname>Kline-Fath</surname><given-names>BM</given-names></name><name name-style="western"><surname>Tkach</surname><given-names>JA</given-names></name><name name-style="western"><surname>Altaye</surname><given-names>M</given-names></name><etal/></person-group><article-title>Prenatal opioid exposure is associated with smaller brain volumes in multiple regions</article-title>. <source>Pediatr Res</source>. (<year>2021</year>) <volume>90</volume>(<issue>2</issue>):<fpage>397</fpage>&#8211;<lpage>402</lpage>. <pub-id pub-id-type="doi">10.1038/s41390-020-01265-w</pub-id><pub-id pub-id-type="pmid">33177677</pub-id><pub-id pub-id-type="pmcid">PMC8110593</pub-id></mixed-citation></ref><ref id="B85"><label>85.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Radhakrishnan</surname><given-names>R</given-names></name><name name-style="western"><surname>Vishnubhotla</surname><given-names>RV</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>Y</given-names></name><name name-style="western"><surname>Yan</surname><given-names>J</given-names></name><name name-style="western"><surname>He</surname><given-names>B</given-names></name><name name-style="western"><surname>Steinhardt</surname><given-names>N</given-names></name><etal/></person-group><article-title>Global brain functional network connectivity in infants with prenatal opioid exposure</article-title>. <source>Front Pediatr</source>. (<year>2022</year>) <volume>10</volume>:<fpage>1</fpage>&#8211;<lpage>10</lpage>. <pub-id pub-id-type="doi">10.3389/fped.2022.847037</pub-id><pub-id pub-id-type="pmcid">PMC8964084</pub-id><pub-id pub-id-type="pmid">35359894</pub-id></mixed-citation></ref><ref id="B86"><label>86.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Radhakrishnan</surname><given-names>R</given-names></name><name name-style="western"><surname>Elsaid</surname><given-names>NMH</given-names></name><name name-style="western"><surname>Sadhasivam</surname><given-names>S</given-names></name><name name-style="western"><surname>Reher</surname><given-names>TA</given-names></name><name name-style="western"><surname>Hines</surname><given-names>AC</given-names></name><name name-style="western"><surname>Yoder</surname><given-names>KK</given-names></name><etal/></person-group><article-title>Resting state functional MRI in infants with prenatal opioid exposure-a pilot study</article-title>. <source>Neuroradiology</source>. (<year>2021</year>) 63(4):585&#8211;91. <pub-id pub-id-type="doi">10.1007/s00234-020-02552-3</pub-id><pub-id pub-id-type="pmid">32978671</pub-id><pub-id pub-id-type="pmcid">PMC9162800</pub-id></mixed-citation></ref><ref id="B87"><label>87.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Uebel</surname><given-names>H</given-names></name><name name-style="western"><surname>Wright</surname><given-names>IM</given-names></name><name name-style="western"><surname>Burns</surname><given-names>L</given-names></name><name name-style="western"><surname>Hilder</surname><given-names>L</given-names></name><name name-style="western"><surname>Bajuk</surname><given-names>B</given-names></name><name name-style="western"><surname>Breen</surname><given-names>C</given-names></name><etal/></person-group><article-title>Reasons for rehospitalization in children who had neonatal abstinence syndrome</article-title>. <source>Pediatrics</source>. (<year>2015</year>) <volume>136</volume>(<issue>4</issue>):<fpage>e811</fpage>&#8211;<lpage>20</lpage>. <pub-id pub-id-type="doi">10.1542/peds.2014-2767</pub-id><pub-id pub-id-type="pmid">26371197</pub-id></mixed-citation></ref><ref id="B88"><label>88.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Corr</surname><given-names>TE</given-names></name><name name-style="western"><surname>Schaefer</surname><given-names>EW</given-names></name><name name-style="western"><surname>Paul</surname><given-names>IM</given-names></name></person-group>. <article-title>Body composition during the first 4 months in infants affected by neonatal abstinence syndrome: a pilot study</article-title>. <source>J Dev Orig Health Dis</source>. (<year>2022</year>) <volume>13</volume>(<issue>1</issue>):<fpage>120</fpage>&#8211;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1017/S2040174421000052</pub-id><pub-id pub-id-type="pmid">33650484</pub-id></mixed-citation></ref><ref id="B89"><label>89.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vance</surname><given-names>J</given-names></name><name name-style="western"><surname>Chant</surname><given-names>D</given-names></name><name name-style="western"><surname>Tudehope</surname><given-names>D</given-names></name><name name-style="western"><surname>Gray</surname><given-names>P</given-names></name><name name-style="western"><surname>Hayes</surname><given-names>A</given-names></name></person-group>. <article-title>Infants born to narcotic dependent mothers: physical growth patterns in the first 12 months of life</article-title>. <source>J Paediatr Child Health</source>. (<year>1997</year>) <volume>33</volume>(<issue>6</issue>):<fpage>504</fpage>&#8211;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1111/j.1440-1754.1997.tb01659.x</pub-id><pub-id pub-id-type="pmid">9484681</pub-id></mixed-citation></ref><ref id="B90"><label>90.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>LaGasse</surname><given-names>LL</given-names></name><name name-style="western"><surname>Gaskins</surname><given-names>RB</given-names></name><name name-style="western"><surname>Bada</surname><given-names>HS</given-names></name><name name-style="western"><surname>Shankaran</surname><given-names>S</given-names></name><name name-style="western"><surname>Liu</surname><given-names>J</given-names></name><name name-style="western"><surname>Lester</surname><given-names>BM</given-names></name><etal/></person-group><article-title>Prenatal cocaine exposure and childhood obesity at nine years</article-title>. <source>Neurotoxicol Teratol</source>. (<year>2011</year>) <volume>33</volume>(<issue>2</issue>):<fpage>188</fpage>&#8211;<lpage>97</lpage>. <pub-id pub-id-type="doi">10.1016/j.ntt.2010.11.002</pub-id><pub-id pub-id-type="pmid">21109003</pub-id><pub-id pub-id-type="pmcid">PMC3058125</pub-id></mixed-citation></ref></ref-list></back></article></pmc-articleset>